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Resumo 
 
A própolis orgânica brasileira é produzida na mata Atlântica dos estados 
brasileiros de Santa Catarina e Paraná (PO). A PO é produzida e certificada 
internacionalmente de forma orgânica e pode ser agrupada em 7 perfis químicos 
distintos com atividades antibacterianas e antioxidantes. A PO perfil 6 (PO6) tem 
destaque entre estes perfis, pois é o único com atividade anti-inflamatória. A presente 
pesquisa teve o objetivo de (1) elucidar os mecanismos de ação anti-inflamatórios da 
PO6; (2) avaliar atividades antifúngicas da PO6; (3) identificar moléculas 
potencialmente bioativas da PO6; e (4) verificar as atividades biológicas e toxicidade 
de giberilinas (classe de terpenoides identificada na PO6). Os resultados mostraram 
que o extrato bruto da PO6 possui potente atividade anti-inflamatória, reduzindo a 
ativação do NF-κB, a liberação de TNF-α e a migração neutrofílica. Também 
mostramos que o extrato bruto da PO6 possui atividade antifúngica in vitro contra as 
espécies Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, e 
Candida parapsisolis (valores de CIM e CFM menores que 200 µg/mL; atividade 
antibiofilme em concentrações 10 e 100 vezes o valor de CIM; e redução da adesão 
das espécies de Candida em queratinócitos humanos em concentrações inferiores ao 
MIC). Nossos resultados também mostraram que doses antifúngicas da PO6 possuem 
baixa toxicidade em modelo in vivo com larvas de Galleria mellonella. Os compostos 
giberilinas A7, A9 e A20; ácido cafeoiltartárico, ácido 3,4-dicafeoiltartárico e quercetina 
foram identificados na PO6 pela técnica de Cromatografia Líquida de Massa Precisa. 
Este foi o primeiro relato da presença de giberilinas em amostras de própolis. As 
giberilinas A4 e A7 (GA4 e GA7) possuem atividades anti-inflamatórias e antifúngicas 
distintas: a GA4 reduz a ativação do NF-κB em macrófagos e não possui atividade 
antifúngica; enquanto que a GA7 possui atividade antifúngica contra a espécie C. 
albicans (valor de CIM de 94 mM, valor de MFC de 188 mM e atividade antibiofilme 
em concentração de 100 vezes o valor de MIC), mas não apresenta atividade anti-
inflamatória. Ambas as GA4 e GA7 possuem atividade antioxidante sequestrante do 
radical livre ROO• e baixo perfil tóxico no modelo de G. mellonella. Desta forma, 
concluímos que: (1) a PO6 possui uma potente atividade anti-inflamatória por meio da 
redução da ativação do NF-κB; liberação de TNF-α e migração de neutrófilos; (2) a 
PO6 possui potente atividade antifúngica contra as espécies mais prevalentes de 
Candida; (3) as moléculas giberilinas A7, A9 e A20; ácido cafeoiltartárico, ácido 3,4-
 
 
dicafeoiltartarico e quercetina podem ser responsáveis por tais efeitos biológicos; e 
(4) a GA4 possui atividade anti-inflamatória, reduzindo a ativação do NF-κB sem 
atividade antifúngica; enquanto que a GA7 possui atividade anti-fúngica contra C. 
albicans, sem apresentar atividade anti-inflamatória; ambas GA possuem atividade 
antioxidante contra o radical peroxil e baixo perfil tóxico. Nossos resultados mostram 
que a PO6 é uma fonte de moléculas bioativas de grande potencial, além de ser um 
produto natural que pode ser usado na prevenção de doenças inflamatórias, fúngicas 
e oxidativas e que a classe das giberilinas pode ser responsável por estes efeitos. 
Palavras-chave: Própolis, produtos orgânicos, produtos naturais, giberilina A7, 
giberilina A9, giberilina A20; ácido cafeoiltartárico, ácido 3,4-dicafeoiltartárico, 
quercetina, Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, 
Candida parapsisolis, macrófagos RAW 264.7, neutrófilos, NETS, CD11b, migração 
neutrofílica, NF-κB, TNF-α, antioxidante, Galleria mellonella. 
  
 
 
Abstract 
Brazilian organic propolis (BOP) is produced in the Brazilian Atlantic 
Rainforest in the states of Santa Catarina and Paraná. BOP is produced and 
internationally certified organically and can be grouped into 7 different chemical profiles 
with antibacterial and antioxidant activities. Among these profiles, BOP profile 6 (PO6) 
is hightlighted as the only BOP profile with anti-inflammatory activity. Therefire, this 
research aimed to (1) elucidate the anti-inflammatory mechanisms of action of BOP6; 
(2) to evaluate BOP6 antifungal activities; (3) to identify potentially bioactive molecules 
from BOP6; and (4) to verify the biological activities and toxicity of gibberellins (class 
of terpenoids identified in BOP6). The results showed that the crude PO6 extract has 
a potent anti-inflammatory activity, reducing the activation of NF-κB, the release of 
TNF-α and neutrophil migration. We also showed that the crude extract of BOP6 has 
antifungal activity in vitro against the species Candida albicans, Candida glabrata, 
Candida tropicalis, Candida krusei, and Candida parapsisolis (MIC and CFM values 
less than 200 µg / mL; antibiofilm activity in concentrations 10 and 100 times the MIC 
value, and reducing the adhesion of Candida species to human keratinocytes at 
concentrations lower than the MIC values). Our results also showed that antifungal 
doses of BOP6 have low toxicity in an in vivo model with Galleria mellonella larvae. 
The compounds gibberiline A7, A9 and A20; cafeoiltartaric acid, 3,4-dicafeoiltartaric 
acid and quercetin were identified at BOP6 by the Precise Mass Liquid 
Chromatography technique. This was the first report of the presence of gibberellins in 
propolis samples. Gibberilins A4 and A7 (GA4 and GA7) have distinct anti-
inflammatory and antifungal activities: GA4 reduces the activation of NF-κB in 
macrophages and has no antifungal activity; while GA7 has antifungal activity against 
the species C. albicans (MIC value of 94 mM, MFC value of 188 mM and antibiofilm 
activity at a concentration of 100 times the MIC value), but it does not have anti-
inflammatory activity. Both GA4 and GA7 have free radical scavenging antioxidant 
activity against ROO• free radical and low toxic profile in the G. mellonella model. Thus, 
we conclude that: (1) BOP6 has a potent anti-inflammatory activity through the 
reduction of NF-κB activation; TNF-α release and neutrophil migration; (2) BOP6 has 
a potent antifungal activity against the most prevalent species of Candida; (3) the 
molecules gibberillins A7, A9 and A20; cafeoiltartaric acid, 3,4-tipfeoiltartaric acid and 
quercetin may be responsible for such biological effects; and (4) GA4 has anti-
inflammatory activity, reducing the activation of NF-κB without antifungal activity; 
 
 
whereas GA7 has anti-fungal activity against C. albicans, without showing anti-
inflammatory activity; both GA have antioxidant activity against the peroxyl radical and 
low toxic profile. Our results show that BOP6 is a source of bioactive molecules with 
great potential, in addition to being a natural product that can be used in the prevention 
of inflammatory, fungal and oxidative diseases and that the class of gibberillins can be 
responsible for these effects. 
Keywords: Propolis, organic products, natural products, Gibberillin A7, Gibberillin A9, 
Gibberillin A20; caffeoyl tartaric acid, 3,4-dicafeoyl-tartaric acid, quercetin, Candida 
albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida parapsisolis, 
RAW 264.7 macrophages, neutrophils, NETS, CD11b, neutrophil migration, NF-κB, 
TNF-α, antioxidant, Galleria mellonella.  
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1 Introdução 
Diversos estudos já demonstraram que a prospecção bioguiada de 
recursos naturais é um método eficaz para descoberta de novas moléculas com 
atividade biológica (Bueno-Silva et al., 2013; Franchin et al., 2016; da Cunha et al., 
2019). Estas moléculas podem ter inúmeras aplicações para as indústrias 
farmacêutica, química, alimentícia, cosmética e de higiene. Em 2014, por exemplo, 
mais da metade dos novos fármacos registrados pelo FDA foram originados de 
produtos naturais ou eram derivados dos mesmos (Newman & Cragg, 2016). 
A própolis é uma destas fontes de recursos naturais, pois é uma mistura 
resinosa coletada por abelhas de brotos e exsudatos de plantas, sendo um reflexo da 
biodiversidade que circunda a colmeia (Park et al., 2002; Silva et al., 2008). Desta 
forma, dependendo da localização geográfica e clima, a própolis pode assumir um 
perfil químico único, tendo diversas propriedades benéficas (Park et al., 2002; 
Franchin et al., 2017). 
Neste contexto, o Brasil tem grande destaque, já que 20% das espécies 
vegetais da Terra estão presentes neste país1, fazendo com que exista grande 
diversidade na composição química das própolis brasileiras (Park et al., 2002). Muitos 
estudos estão sendo realizados com o objetivo de isolar e identificar os compostos 
bioativos destas resinas para que possam ser aplicados como novos agentes 
terapêuticos (Franchin et al., 2012; Bueno-Silva et al., 2013; Ribeiro-Junior et al., 
2015). 
Diversas moléculas ativas já foram identificadas, como por exemplo o 
artepelim C (Ahn et al., 2007), que tem atividade anticâncer; e o CAPE (caffeic acid 
phenyl ester), que inibe a adipogênese e diminui a resistência à insulina (Bezerra et 
al., 2012). A apigenina e o tt-farnesol também foram isolados da própolis brasileira e 
possuem atividade antimicrobiana, anticárie, antibiofilme oral e outras, com patente  
depositada nos Estados Unidos da América, Canadá, 8 países da Europa, Japão e 
China, pelo grupo de pesquisadores da FOP e da University of Rochester2 (Koo et al., 
2003). 
 
1 https://www.mma.gov.br/biodiversidade/biodiversidade-brasileira 
2 Patente Internacional: Numbers: WO200247615-A2; AU200231030-A. Title: New oral compositions comprising a 
terpenoid and a flavonoid, useful for treating dental caries, dental plaque formation, gingivitis, candidiasis, dental 
stomatis, aphthous ulceration or fungal infections. Inventor Name(s): BOWEN W H, KOO H, PARK Y K, CURY J 
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A atividade anti-inflamatória das própolis brasileiras também tem sido 
pesquisada e sua capacidade de interferir diretamente em alguns alvos específicos 
dentro do processo inflamatório vem chamando a atenção da comunidade científica, 
como é o caso da inibição da migração neutrofílica (Paulino et al., 2003; Franchin et 
al., 2017; Nani et al., 2018; da Cunha et al., 2019). O grande atrativo desta estratégia 
de combate a inflamação é que ela é mais seletiva quando comparada à estratégias 
convencionais, apresentando maior eficácia e menos efeitos adversos (Laveti et al., 
2013). Este tipo de abordagem baseia-se na inibição de citocinas, quimiocinas, 
proteínas de adesão e rolamento ou transmigração destas células para o foco 
inflamatório (Mackay, 2008). 
A migração dos neutrófilos é de grande importância no complexo conjunto 
de eventos inflamatórios, pois quando próximos dos tecidos lesados, os neutrófilos 
tornam-se ativos e cruciais no combate aos agentes infecciosos, seja por 
reconhecimento destes agentes ou por combate direto (Wright et al., 2010). A ativação 
destas células ocorre na presença de mediadores químicos liberados por células 
residentes, como o fator de necrose tumoral alfa (TNF-α) e as quimiocinas CXCL1/KC 
e CXCL2/MIP-2, que promovem a exposição de receptores inflamatórios pré-formados 
em suas membranas que aumentam sua função, vida útil e, principalmente, sua 
afinidade por células endoteliais, iniciando assim o processo de diapedese 
(Huttenlocher et al., 1995; Wagner & Roth, 1999). 
A diapedese consiste na mobilização adequada e em tempo hábil dos 
neutrófilos da microcirculação para o sítio inflamatório (Huttenlocher et al., 1995). O 
processo é intermediado por proteínas de membrana que são expressas em 
neutrófilos e células endoteliais. Estas proteínas realizam uma interação inicial fraca, 
mas suficiente para que estas células passem a percorrer o endotélio “rolando” pela 
parede endotelial. O rolamento promove alterações conformacionais nas proteínas de 
membrana, tornando-as passíveis de realizar interações mais fortes com as moléculas 
de adesão intercelulares e vasculares endoteliais, principalmente a ICAM-1. Quando 
esta interação ocorre, há adesão do neutrófilo à parede venular. A aderência permite 
que os neutrófilos migrem por entre as adjacências de células endoteliais vizinhas ou 
 
A, ROSALEN P L. Patent Assignee Names: UNIV ROCHESTER (UYRP); UNICAMP UNIV ESTADUAL CAMPINAS 
(UNIC-Nonstandard). 
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transmigrem através de uma delas por meio de poros celulares, chegando finalmente 
ao tecido inflamado (Wright et al., 2010). 
No tecido, os neutrófilos movimentam-se a favor do gradiente de moléculas 
quimiotáticas, produzidas em grande parte por macrófagos residentes. Desta forma, 
chegam ao foco inflamatório, onde desempenham um papel importante no combate 
aos agentes agressores utilizando toda sua maquinaria para isto (Wright et al., 2010; 
Nussbaum & Shapira, 2011). 
Apesar de serem fundamentais no combate a agentes infecciosos, em 
algumas ocasiões os neutrófilos tornam-se destrutivos para os tecidos do hospedeiro 
(Wright et al., 2010). Um exemplo disso é a doença periodontal, que é caracterizada 
por uma disbiose no biofilme presente no tecido periodontal e é agravada pela 
migração e atividade desbalanceada dos neutrófilos (Nussbaum & Shapira, 2011). 
Outras doenças, como a artrite reumatoide e a doença pulmonar obstrutiva crônica 
também parecem ser agravadas pela atividade neutrofílica exacerbada (O'Donnell et 
al., 2004; Wong & Lord, 2004). 
Dentro deste contexto, nosso grupo de pesquisa vem trabalhando com um 
tipo específico de própolis brasileira, que é produzida e creditada 3de forma orgânica, 
a própolis orgânica (PO). Esta própolis apresenta um grande potencial para 
descoberta de novas moléculas e tem chamado a atenção do mercado brasileiro, 
europeu e asiático graças ao seu sabor suave e ausência de metais pesados e 
pesticidas. Tais características estão relacionadas à sua origem orgânica, sendo 
produzida exclusivamente em matas nativas (Mata Atlântica), de reflorestamento, de 
áreas de preservação permanente ou reserva legal; e tornam esta amostra de própolis 
de grande valor, uma vez que a presença de contaminantes nestes produtos naturais 
e nas colmeias tem sido relatada por diversos pesquisadores (González-Martín et al., 
2017; Gooley et al., 2018; Calatayud-Vernich et al., 2019). 
Recentemente, nosso grupo de pesquisa avaliou a composição química da 
PO por meio de cromatografia em camada delgada (CCD) e cromatografia líquida de 
alta eficiência (CLAE). Os resultados mostram que a PO pode ser agrupada em 7 
perfis químicos diferentes, todos com alta capacidade antioxidante (Tiveron et al., 
 
3 Normas de certificação internacional NOP (USDA) e CEE (europeia) (processo nº 23511) e Brasil 
Orgânico (processo nº 11-0030.11). 
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2016). Além disso, mostramos que os extratos da PO são ricos em três ácidos 
fenólicos (ácidos gálico, cafeico e cumárico), um derivado fenilado do ácido cinâmico 
(artepelin C) e um flavonoide (pinocembrina), entre outros compostos (Tiveron et al., 
2016). Apesar destes compostos serem comuns em própolis brasileiras, outros 
compostos foram detectados e não identificados, mesmo quando comparados a vários 
outros padrões comumente encontrados em própolis brasileiras (Tiveron et al., 2016). 
Compostos nunca antes identificado em amostras de própolis foram identificados em 
amostras de PO. Os compostos pertencem à classe das lignanas e de seus 
precursores. Estas moléculas apresentam fortíssima atividade antioxidante e quatro 
delas são inéditas em própolis (lariciresinol, secoisolariciresinol, matairesinol e 
balajaponina D – dados ainda não publicados). Estas características tornam a 
composição fitoquímica da PO única, levantando a discussão sobre a PO ser 
caracterizada como um novo tipo de própolis brasileira. 
Além de atividade antioxidante, também mostramos que diversos perfis da 
PO possuem atividade antimicrobiana contra as bactérias: Streptococcus mutans, 
Streptococcus oralis, Streptococcus sobrinus, Staphylococcus aureus, Pseudomonas 
aeruginosa, e Escherichia coli (Tiveron et al., 2016).  
De forma interessante, o perfil 6 da PO (PO6) foi o único que não 
apresentou atividades antioxidantes e antibacterianas relevantes, destacando-se 
negativamente nestes quesitos quando comparada aos outros perfis da PO (1 – 5 e 
7). Entretanto, somente a PO6 apresentou atividade anti-inflamatória, sendo capaz de 
inibir a liberação e/ou produção da citocina TNF-α por meio da inibição da ativação do 
fator de transcrição NF-κB (Tiveron et al., 2016) e de promover “downregulation” de 
genes envolvidos com a retração e com a produção da força motriz endotelial e 
leucocitária, fatores que culminam no influxo de neutrófilos para o foco inflamatório. 
Desta forma, nossos achados são indicativos de que a PO6 é uma nova e 
excelente fonte de compostos anti-inflamatórios com atividade inibidora da migração 
de neutrófilos e tem grande potencial de aplicação na indústria farmacêutica. Nossa 
hipótese inicial é que a bioprospecção da PO6 pudesse resultar no isolamento e 
identificação de moléculas anti-inflamatórias com potencial para tratamento de 
doenças inflamatórias de caráter imunomodulatório.  
Além disso, infecções fúngicas também são um fator importante que aflige 
a colmeia e pode colocar em risco a produção apícola (Grabowski & Klein, 2017), 
18 
 
sendo benéfico para as abelhas e para os apicultores ter na composição fitoquímica 
da própolis moléculas com propriedades antifúngicas. Ainda, há uma carência 
mercadológica por moléculas e produtos com atividades antifúngicas, em especial 
contra espécies de Candida. 
Desta forma, o objetivo deste trabalho foi: aprofundar o estudo de 
atividades anti-inflamatórias da PO6; avaliar atividades antifúngicas da PO6; 
identificar moléculas potencialmente bioativas da PO6; e verificar as atividades 
biológicas e toxicidade de giberilinas (classe de terpenoides identificada na PO6). 
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Anti-inflammatory and anti-Candida effects of Brazilian organic 
propolis, a promising source of bioactive molecules and functional 
food 
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Adna Prado Massariollib, Thiago Mattar Cunhac, Severino Matias de Alencarb, Marcelo Franchina*, 
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*Corresponding authors 
Brazilian organic propolis (BOP) is an unexplored Brazilian propolis that is produced 
organically and certified according to international legislation. Our results showed that 
BOP has strong anti-inflammatory effects and acts by reducing NF-кB activation, TNF-
α release and neutrophil migration. In addition, BOP exhibited antifungal activity on 
planktonic and biofilm cultures of Candida albicans, C. glabrata, C. tropicalis, C. krusei 
and C. parapsisolis, and it reduced in vitro yeast cell adhesion to human keratinocytes 
at sub-inhibitory concentrations. BOP demonstrated significantly low toxicity in Galleria 
melonella larvae at antifungal doses. Lastly, a chemical analysis revealed the presence 
of caffeoyltartaric acid, 3,4-dicaffeoylquinic acid, quercetin, gibberellin A7, A9 and A20 
in BOP, which may be responsible for the biological properties observed. Thus, our 
data indicate that BOP is a promising source of anti-inflammatory and antifungal 
molecules that may be used as a functional food. 
 
4 Tese defendida no formato alternativo, conforme a Deliberação da Congregação da FOP Nº 306/20102 disponível 
em: https://www.fop.unicamp.br/cpg/index.php/consultas/manual-normatizacao-teses 
5 https://doi.org/10.1021/acs.jafc.8b07304 (Impact Factor 2018: 3.571; Citations 2018: 109,151) 
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Dicaffeoylquinic acid; 3,4-diCQA; Quercetin; Gibberellin.  
1. Introduction 
Natural products are an important source of bioactive compounds. 
According to Newman and Cragg (2016), 60% of the small molecules approved by the 
FDA correspond to unaltered or derivative natural products, as opposed to 40% of 
synthetic origin1. Propolis, a resin collected by bees from the exudates of plants 
surrounding the beehive2, has great importance in this scenario as several bioactive 
molecules have been isolated therefrom over the last years, for instance, artepillin C3; 
caffeic acid phenyl ester4; apigenin and tt-farnesol5; cinnamoyloxy-mammeisin6; 
neovestitol and vestitol7, 8. 
Brazil is one the most biodiverse countries worldwide, with a great potential 
for the discovery of new prototype drugs. In addition, Brazilian natural products may 
also be commercially explored as functional foods or nutraceuticals. Both approaches 
may increase the financial value of natural resources with income generation while 
conserving national reserves and biomes. This is very relevant if it is considered that 
tropical rainforests account for about two-thirds of all habitats worldwide. In addition, 
out of the 14 to 20 million square kilometers cataloged thus far, only half of the original 
area remains untouched in the present days9. 
The great biodiversity in Brazil is directly reflected in the botanical origin and 
phytochemical composition of propolis. Different types of Brazilian propolis have been 
described in the literature. Park and collaborators (2012) were one of the first to report 
the variety of Brazilian propolis. The authors were able to correlate the chemical 
composition of propolis with the resins of three specific trees, namely: type 3, known 
as Poplar propolis (collected by bees from Populus L. trees, Salicaceae Family); type 
6 or brown propolis (collected by bees from Hyptis divaricate); and type 12 or green 
propolis (collected by bees from Baccharis dracunculifolia). More recently, type 13 or 
red propolis (collected by bees from Dalbergia ecastophyllum) had its botanical origin 
identified10-12. Acting as pollinators and spreaders of biodiversity, bees are commonly 
important members within an ecosystem. Interestingly, all of these Brazilian propolis 
types are produced by Apis mellifera Africanized bees, an exotic bee species that was 
introduced into the Brazilian environment accidentally during the European 
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colonization and then Africanized during an accidental release of a population of 
Africanized bees in Sao Paulo state13.  
More recently, our research group has studied the phytochemistry and 
biological properties of an unstudied Brazilian A. mellifera propolis, which is produced 
under strict organic conditions in Brazil’s Atlantic rainforest (Paraná and Santa 
Catarina states), with international certification. We named this peculiar Brazilian 
propolis as Brazilian organic propolis (BOP). Our previous report showed that this 
propolis has great phytochemical variability, with seven different chemical profiles 
identified by thin layer chromatography (TLC) and high performance liquid 
chromatography (HPLC)14. In that occasion, we showed that most of the BOP chemical 
profiles presented some antioxidant and antimicrobial activity, except for BOP profile 
6 (BOP6). Interestingly, BOP6 did not exhibit such biological properties, but was the 
only propolis profile able to inhibit NF-кB activation and TNF-α release, which are key 
targets for the treatment of chronic inflammatory diseases14.  
As mentioned earlier, in some occasions, bees look for specific plant 
exudates to produce propolis. In general, this behavior protects the beehive from 
parasitism by mammals and insects and from weather-related adversities. Therefore, 
we assume that bees located in organic environments have more plant options to 
produce propolis. In such a case, the bees may adapt the propolis composition from a 
variety of exudates according to the challenges encountered in the beehive.  
Considering the previous findings on BOP6 anti-inflammatory potential, we 
investigated herein the anti-inflammatory and antifungal effects of BOP6 and its 
mechanisms of action and toxicity in vivo. In addition, a chemical analysis of BOP6 
was performed to identify the chemical compounds that may be responsible for the 
biological properties observed. Taken altogether, our findings indicate that BOP6 may 
be used as a new source of bioactive molecules and functional food. 
2. Material and methods  
2.1. Reagents 
Ethanol, dimethyl sulfoxide (DMSO) and lipopolysaccharides from 
Escherichia coli B4 (LPS) were purchased from Merck (Sao Paulo, SP, Brazil). Roswell 
Park Memorial Institute 1640 medium (RPMI), Dulbecco's Modified Eagle Medium 
(DMEM), penicillin, L-glutamine, thiazolyl blue tetrazolium bromide (MTT) and 
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amphotericin B were purchased from Sigma-Aldrich (St. Louis, MO, USA). Luciferase 
assay reagent containing luciferin was purchased from Promega (Madison, WI, USA). 
TNF-α sandwich ELISA kit was purchased from R&D Systems (Minneapolis, MN, 
USA). Fetal bovine serum was purchased from Gibco (Grand Island, NY, USA). Yeast 
Nitrogen Base medium (YNB) and Sabouraud Dextrose Agar medium (SDA) were 
purchased from BD Difco (Franklin Lakes, NJ, USA). 
2.2. Propolis collection and extraction 
Apis mellifera BOP6 samples were collected from the internal parts of the 
beehives. Sample collection occurred between June and August 2016 in the city of 
Palmital (SL 2453'35" and WL 5212'10"), Paraná state (Southeastern Brazil). The 
access to Brazilian genetic heritage was requested in accordance with the Brazilian 
legislation SECEX/CGEN Ordinance No. 1 and registered on the SISGEN platform 
under accession number A5A0509. 
For sample extraction, 100 g of propolis were mixed with 25 mL of ethanol 
(80%, w/v) at 70°C for 30 min. The extract was cooled down in a refrigerator overnight 
and filtered to remove the wax. The ethanol content was evaporated, and water was 
removed by freeze-drying to obtain the BOP6. The BOP6 extracted for this study was 
compared to that of a previous report14. Both samples presented a similar 
chromatographic profile in thin layer chromatography and high-resolution liquid 
chromatography assays.  
BOP6 was initially diluted in DMSO (highly concentrated) and then in culture 
media for in vitro inflammatory and antifungal assays, or in saline solution for in vivo 
experiments (neutrophil migration and toxicity assays). In all cases, the final 
concentration of DMSO in BOP6 was lower than 0.5%. This vehicle was used as a 
negative control in the experiments. 
2.3. Inflammation assays  
2.3.1. Culture conditions and in vitro viability assay (MTT) 
To test the BOP6 in vitro anti-inflammatory effects and mechanisms of 
action, we used RAW 264.7 macrophages stably transfected with NF-κB luciferase 
reporter gene. Cells were cultured in RPMI supplemented with 10% fetal bovine serum 
(SFB), 100 U/mL penicillin and 2 mM L-glutamine, incubated at 37°C in 5% CO2 
atmosphere. Initially, the effects of BOP6 on macrophage viability were determined by 
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the MTT method15, 16. Briefly, cells were seeded onto 96-well plates (2 x 105 cells/well) 
and incubated overnight in supplemented RPMI. The cells were treated with BOP6 at 
0.1, 1, 10 and 100 µg/mL and incubated in plain RPMI for 24 h at 37°C in 5% CO2. 
Later, the supernatant was discarded and 0.3 mg/mL MTT in plain RPMI was added 
to the wells and incubated for 3 h. The supernatant was discarded and 200 µL of DMSO 
was added to each well. The absorbance of the lysates was measured at 570 nm in a 
microplate reader. The assays were carried out in quadruplicates of three independent 
experiments17. The results were expressed as viability percentage in relation to the 
negative control group. 
2.3.3. Viability Assay by Flow Cytometry (Annexin V and Propidium Iodide (PI)) 
To evaluate if BOP6 induces necrosis and apoptosis, the flow cytometry 
with the annexin V and propidium iodide (PI) stains assay was performed. Briefly, 
macrophages were cultured in the presence of BOP6 at 10 µg/mL or the vehicle in six-
well plates at 1 × 106 cells/well density. After treatment, the cells were washed and 
suspended in annexin buffer and anti-annexin V-FITC antibody (1:300). The cell 
suspension was incubated at 4 °C for 30 min. Afterwards, the anti-PI antibody (1:100) 
was added and the flow cytometry was conducted in the FACSVerse equipment (BD 
Biosciences, San Diego, CA, USA). Data were analyzed with FlowJo software (Tree 
Star, Ashland, OR, USA). Procedures were conducted in three separate experiments 
as described previously17. Approximately 10.000 gated events were collected in each 
analysis. 
2.3.3. In vitro NF-кB activation and TNF-α quantification assays 
Macrophages (3 x 105 cells/well) were adhered to 24-well plates in 
supplemented RPMI overnight. The cells were incubated in the presence of the BOP6 
at 0.1, 1 and 10 µg/mL in plain RPMI for 30 min at 37°C in 5% CO2. Then the cells 
were stimulated with LPS (10 ng/mL final concentration) for 4 h. After treatment and 
stimulus, the supernatant was collected to check for TNF-α dosage by sandwich 
ELISA. Remaining cells were used to determine the NF-кB activation status. Briefly, 
cells were lysed with Tris-NaCl-Tween buffer; 10 µL of the lysate was mixed with 25 
µL of the luciferase assay reagent containing luciferin in a 96-well opaque plate. 
Luminescence was quantified in a microplate reader (Molecular Devices). All assays 
were carried out in quadruplicates of three independent experiments17, 18. The results 
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are expressed as relative luminescent units (NF-кB activation level) or as pg/mL of 
TNF-α in relation to the stimulated untreated control group. 
2.3.4. In vivo neutrophil migration assay 
To confirm the BOP6 in vivo anti-inflammatory activity, C57BL/J6 SPF male 
mice were used in a neutrophil migration assay. Animals weighing between 20 and 22 
g were purchased from CEMIB/UNICAMP (Multidisciplinary Center for Biological 
Research, SP, Brazil). Six animals were used per group and all procedures were 
previously approved by Institutional Animal Care and Use Committee 
(CEUA/UNICAMP, approval number 4370-1). The mice were kept at 22-25 °C with 
food (standard pellet diet, Presence) and water ad libitum under controlled light/dark 
cycle and humidity (40-60%). Animals were treated orally with BOP6 (3, 10 and 30 
mg/Kg), saline solution (negative control) or dexamethasone (2 mg/Kg; gold standard 
positive control) for 30 min and stimulated with carrageenan (500 µg per cavity) in the 
peritoneum. After 4 hours of treatment and peritoneal inflammatory stimulus, the 
animals were euthanized, and their peritoneal cavity was washed with 1 mM EDTA 
(Sigma) in PBS solution. The peritoneal wash fluid was collected for total and 
differential cell counting. The assays were carried out in three independent 
experiments17, and the results are expressed as the number of migrated neutrophils 
per cavity.  
2.4. Antifungal assays  
2.4.1. Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration 
(MFC) assays 
Five Candida spp. strains were used to determine the antifungal activity of 
BOP6, namely: Candida albicans (MYA 2876), C. glabrata (ATCC 90030), C. tropicalis 
(ATCC 750), C. krusei (ATCC 6258) and C. parapsisolis (ATCC 22019). The Minimum 
Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC) of BOP6 
was determined by the microdilution method according to CLSI protocols (CLSI, 2002). 
Briefly, an inoculum (103 UFC/mL) was prepared in RPMI medium supplemented with 
L-glutamine (2 mM), glucose (2%) and MOPS buffer (final pH - 7.0). BOP6 was diluted 
in RPMI medium and tested at concentrations ranging from 6.25 to 400 µg/mL. 
Amphotericin B (AmB) was used as a positive gold standard control at concentrations 
ranging from 0.03 to 4 µg/mL. The plates with the inocula and treatments were 
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incubated statically for 24 h. The MIC was determined visually as the lowest 
concentration of the drug that did not produce any visual turbidity in the wells. Aliquots 
from the wells with no visual fungal growth were plated onto SDA and incubated for 24 
h in aerobic atmosphere. The MFC was defined as the lowest concentration of the 
subculture at which no visible growth was observed on solid media. The assays were 
carried out in triplicates of three independent experiments. 
2.4.2. Mature biofilm assay 
C. albicans, C. glabrata, C. tropicalis, C. krusei and C. parapsilosis biofilms 
were formed in 96 well plates by adding 200 μL of inoculum (108 cells/mL) in YNB. The 
plates were incubated statically for 24 h at 37°C in aerobic atmosphere for mature 
biofilm formation. The supernatant was discarded, and the wells were washed to 
remove non-adhered cells. BOP6 or AmB (positive gold standard) were prepared in 
YNB at concentrations equal to, or ten-fold higher, the MICs. Mature biofilms were 
treated for 1 or 2 hours at 37°C in aerobic atmosphere. The supernatants were 
discarded, and the wells were washed to remove non-adhered or killed cells. The 
biofilms were homogenized, serially diluted and plated for colony-forming units (CFUs) 
onto SDA. The plates were incubated at 37°C for 24 h in aerobic atmosphere and 
colonies were counted. The assays were carried out in triplicates of three independent 
experiments19. The results are expressed as percent survival in relation to the 
untreated group. 
2.4.4. Human Keratinocytes adhesion assay 
The effects of BOP6 on yeast adhesion to epithelial cells were evaluated as 
previously described20. Human keratinocytes (HaCat) obtained from the Cell Bank of 
Rio de Janeiro (Brazil) were cultivated in DMEM supplemented with bovine fetal serum 
(10%), penicillin (100 U/mL), streptomycin (100 μg/mL) and L-glutamine (200 mM) at 
37°C in 5% CO2 atmosphere. HaCat cells were adhered onto 96-well plates (105 
cells/well). When a 90% confluence was obtained, the supernatant was discarded and 
cell suspensions of C. albicans, C. glabrata, C. tropicalis, C. krusei or C. parapsilosis 
were added to the wells (103 cells/well) in the presence of BOP6 or AmB at sub-
inhibitory concentrations (half of the MIC). The plates were incubated at 37°C in 5% 
CO2 for 2 h or 3 h. The supernatant containing keratinocytes and non-adhered yeast 
cells was discarded. Adhered cells were washed three times with PBS and trypsinized. 
An aliquot of 20 μL of the suspended cells was plated for CFUs onto SDA and 
26 
 
incubated at 37°C in 5% CO2 atmosphere for 24 h. Yeast adhesion to keratocytes was 
determined in relation to the total number of adhered cells in the untreated control 
group. The assays were carried out in triplicates of three independent experiments. 
2.5. In vivo toxicity and treatment of systemic Candida spp. infection  
The acute toxicity of BOP6 was determined in vivo in Galleria mellonella 
larvae. This is a model broadly used in the international literature whose results 
correlate with those found in mammals21. G. mellonella larvae were maintained at 37 
°C in a BOD incubator until use. To evaluate the acute toxic effects of BOP6, high 
doses of the extract (0.75, 1.5, 3 and 6 g of BOP6 per kilogram of larvae) were injected 
into the larva hemocoel via the last left proleg using a 25 μL Hamilton syringe. In each 
group, ten larvae with no signs of melanization and weight between 0.2 and 0.3 g were 
randomly selected. All groups were incubated at 37 °C, and their survival was 
monitored at selected intervals for up to 72 h. The larvae showing high melanization 
and absence of movements upon touch were counted as dead. 
Next, we investigated the BOP6 therapeutic potential to treat C. albicans 
systemic infection in G. mellonella.  A cell culture of C. albicans was grown as 
previously described. The inoculum was diluted in 0.9% NaCl and standardized to 
5x107 cells in a spectrophotometer. Three groups of 10 larvae were injected 10 µl of 
inoculum via the last left proleg of each larva. One hour after infection, the larvae were 
injected via the last right proleg with the following treatments: group 1 (BOP6 - 20 
mg/mL); group 2 (AmB - 50 µg/mL); group 3 (0.9% NaCl solution). An uninfected 
control group was included, which was administered with only 0.9% NaCl.  The larvae 
were incubated at 30 °C, and their survival was monitored every 9 h until the maximum 
time of 48 h. The survival of the larvae was recorded as previously mentioned (no 
movements detected upon touch). All assays were carried out in triplicates of three 
independent experiments19.  
 
2.6. Chemical analysis by high definition accurate-mass (LC–ESI-QTOF-MS)  
Liquid chromatography analysis was performed using a Shimadzu 
chromatograph (Shimadzu Co., Tokyo) equipped with a LC-30AD quaternary pump, 
photodiode array detector, and a SIL-30AC self-injector. Chromatographic separation 
was performed on a Phenomenex Luna C18 column (4.6 x 250 mm x 5 μm). The 
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MAXIS 3G Bruker Daltonics high-resolution mass spectrometer (Bruker Daltonics, 
Bremen, Germany) was equipped with an electrospray ionization (ESI) source, 
operating in negative mode, with a nominal resolution of 60,000 m/z. The operating 
conditions were set as follows: nebulizer - 2 Bar; dry gas - 8 L/min; temperature - 200 
°C; and HV - 4500 V. The mobile phase consisted of a mixture of two solvents: (A) 
0.5% acetic acid and 99.5% water; and (B) 100% methanol. The flow rate of the mobile 
phase was 0.8 mL/min. The gradient was started with 30% of solvent B; increasing to 
60% in 45 min, 75% in 85 min, 90% in 90 min, resuming to 30% in 105 min and finishing 
the run in 105 min. Before the analysis, an external calibration was performed to 
determine the accuracy of the masses measured. Data analysis was performed using 
MAXIS 3G software (Bruker Daltonics, version 4.3), and the identification of the 
compounds was made by comparing the exact masses, MS/MS mass spectra and 
molecular formulas to the database available in the literature. 
2.7. Statistical Analysis 
A preliminary check of the data for homoscedasticity and normality indicated 
a normal distribution. The data were analyzed by one-way ANOVA followed by Tukey’s 
(MTT assay; NF-кB; TNF-α; Neutrophil Migration) or Dunnet’s (mature biofilm; and 
keratinocyte adhesion) post-hoc tests. Percent survival of G. mellonella larvae was 
compared using the Log-rank Mantel-Cox test. In the neutrophil migration assay, the 
experimental group size was calculated a priori, considering a 25% difference between 
the means of the groups and a 10% standard deviation. The sample size of six animals 
per group provided 80% of power, considering a 5% alpha error. In all experiments, 
the significance level was set at 5%, and the analysis was performed using GraphPad 
Prism v. 6.0 for Windows (GraphPad Software Inc., Los Angeles, USA). 
3. Results and Discussion  
In the present study, we report the anti-inflammatory and antifungal activity 
of an unexplored Brazilian organic propolis (BOP6) and further elucidate its 
phytochemical profile. Our results show that BOP6 has strong anti-inflammatory and 
antifungal effects that may protect mammals from opportunistic fungal infections and 
inflammatory diseases. Moreover, BOP6 showed low acute toxicity in an in vivo model. 
These effects may be attributed to the presence of polyphenols and terpenoids in 
BOP6, which is further discussed in this section. 
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3.1. Anti-inflammatory effects and mechanism of action 
Previously, our research group reported for the first time the chemical 
composition and biological properties of Brazilian organic propolis (BOP) produced 
under strict organic conditions14. BOP was classified into seven different profiles by 
TLC and HPLC analysis (BOP profiles #1 to #7), among which the profile #6 (BOP6) 
was the only sample showing anti-inflammatory properties. These findings encouraged 
us to further investigate the BOP6 anti-inflammatory activity and corresponding 
mechanism(s) of actions. 
At the concentrations of 0.1, 1 and 10 µg/mL, BOP6 did not affect 
macrophage viability (Figure 1A) (p < 0.05). To confirm the non-toxicity of the BOP6 
treatment at 10 µg/mL, we performed a flow citometry (annexin V and PI) assay, which 
showed that BOP6 treatment does not produce apoptotic and necrotic effects to the 
macrophages (Figure 1B). Moreover, treatment with BOP6 at 10 µg/mL reduced 78% 
NF-кB activation (Figure 2A; p < 0.05) and 75% TNF-α release (Figure 2B; p < 0.05) 
in macrophages in relation to the LPS-stimulated group. 
 
Figure 1. In vitro BOP6 effects on macrophage viability: BOP6 is nontoxic up to 10 µg/mL on MTT 
method (A); and do not increase cell apoptosis and necrosis at 10 µg/mL by flow citometry method - 
annexin V and PI (B). Figure A shows the BOP6 cytotoxicity evaluated by the MTT method. Groups: 
“Vehicle” (treated with saline); “0.1”, “1”, “10” and “100” (treated with 0.1, 1, 10 and 100 µg/mL of BOP6, 
respectively). Figure B shows the macrophage early apoptosis, late apoptosis and necrosis; evaluated 
by flow citometry with Anexin-V and PI after treatment with BOP6 at 10 µg/mL (numbers on the dot plot 
represents the percentage of cells cored with anexin-V and/or PI). In both graphics (Figure 1A and 1B) 
different letters indicate statistical difference between the evaluated groups (p<0.05; ANOVA and 
Tukey). 
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Figure 2. In vitro BOP6 effects on macrophage cells: BOP6 reduce the NF-кB activation (A) and TNF-
α release (B) at 10 µg/mL. Macrophages were incubated with the BOP6 (groups “0.1”, “1” and “10”) or 
the vehicle (group “Vehicle” and “-“). After 30 min, BOP6 treated groups and vehicle group received the 
LPS stimulus. Later, all groups cells were submitted to macrophage NF-кB activation assay (luciferase 
assay; Figure 2A) and supernatant was used to measure TNF-α levels (ELISA assay; Figure 2B). 
Different letters indicate statistical difference between the evaluated groups; (p<0.05, ANOVA with 
Tukey’s post-test). Groups: “Vehicle” (treated with vehicle and not induced); “-” (treated with vehicle and 
stimulated with LPS); “0.1”, “1” and “10” (treated with 0.1, 1 and 10 µg/mL of BOP6, respectively, and 
induced with LPS). 
The effects of BOP6 in reducing NF-кB activation and TNF release allowed 
us to hypothesize that this propolis may diminish neutrophil migration into the 
inflammatory focus, which is an interesting approach to treat chronic inflammatory 
diseases. To prove this hypothesis, we used a carrageenan-induced peritonitis model 
in mice. As shown in Figure 3A, the results demonstrate that BOP6 significantly 
reduced neutrophil migration by 52% and 64% when administered at the doses of 10 
mg/Kg and 30 mg/Kg, respectively. Similarly, treatment with BOP6 at the same doses 
(10 mg/Kg and 30 mg/Kg) reduced TNF-α release by 40% and 63%, respectively 
(Figure 3B). 
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Figure 3. In vivo effects of BOP6 on carrageenan-stimulated C57BL mice: BOP6 reduced neutrophil 
migration (A) and TNF-α release (B) at the doses of 10 mg/kg and 30 mg/kg. C57BL mice were treated 
with the BOP6 extract or the vehicle and had a carrageenan-induced peritoneal inflammation stimulated. 
After 4 hours, the animals were sacrificed, and the peritoneal lavage was collected for differential 
neutrophil counts and TNF-α dosage. Groups: “vehicle” (treated with vehicle and not stimulated); “-” 
(treated with vehicle and stimulated with carrageenan); “3”, “10” and “30” (treated with 3, 10 and 30 
mg/kg of BOP6, respectively, and stimulated with carrageenan). Different letters indicate statistical 
difference between the evaluated groups (p<0.05, ANOVA with Tukey’s post-test).  
Although the effect of BOP6 on neutrophil migration and TNF-α release did 
not achieve basal levels (non-stimulated group), we point out that BOP6 corresponds 
to a mixture of molecules present in very low concentrations. It is possible that the 
inhibitory effects on neutrophil migration could have been even more pronounced if 
BOP6 compounds had been tested separately. In addition, a pharmacological 
synergism among BOP6 bioactive molecules should also be considered. 
Our data indicate that BOP6 reduces NF-кB activation, which leads to a 
decrease in TNF-α release and then in neutrophil migration. These outcomes are 
considered important targets in the treatment of chronic inflammatory and autoimmune 
diseases.  
Neutrophils are the most numerous cells in human blood. It is estimated that 
approximately 100 billion neutrophils enter and leave the bloodstream every day22. 
Neutrophils modulate the innate host response against bacterial infections23 and are 
extremely important for human innate immunity. Therefore, when individuals develop 
neutropenia or neutrophil malfunction, they are expected to be at a significantly higher 
risk for life-threatening bacterial infections24. These cells have a sophisticated 
machinery to overcome infection by destroying invading microorganisms. Some of 
these mechanisms include intense production of reactive oxygen species, cytotoxic 
granule components, antimicrobial peptides, and neutrophil extracellular traps, which 
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create a highly lethal environment that is essential for efficient microbial killing and 
degradation 25. 
Nevertheless, in some chronic inflammatory diseases, the exacerbated 
activity of neutrophils does not result in the resolution of the infectious process, as 
some microorganisms are able to survive their antimicrobial arsenal25. For instance, 
periodontal disease is a condition caused by the accumulation of bacteria in the 
periodontal tissue that is exacerbated by the presence of neutrophils. In this case, the 
defense cells may prove unable to reduce the presence of pathogens, instead they 
may cause severe tissue damage26. 
In autoimmune diseases, the exacerbated activity of neutrophils is even 
more critical. In such a case, neutrophils are attracted to non-infected tissues and 
cause unnecessary injuries therein, thereby aggravating the evolution of conditions 
such as lupus27, multiple sclerosis, psoriasis28, and rheumatoid arthritis29. Currently, 
most of the anti-inflammatory drugs available in the market are expensive, ineffective 
and/or cause important side effects that make treatment impracticable30. 
Therefore, the inhibition of neutrophil migration has been considered a very 
promising target to develop new drugs for the treatment of inflammatory and 
autoimmune diseases31. One important mediator of neutrophil migration is the 
activation of the nuclear transcription factor kappa B (NF-кB). NF-кB is activated in 
many different cell types, including neutrophils, resident macrophages, dendritic cells 
and others32.  
Here, we determined NF-кB activation after LPS stimulus using the 
luciferase assay on macrophages transfected with the gene p-luc. These cells were 
chosen since they express luminescence in the presence of the luciferase reagent in 
the occasion of NF-кB activation. Briefly, p-luc macrophages have a reporter region for 
the NF-кB and the gene encoding the luciferase enzyme, so when the transcription 
factor binds to its target on the nucleus, luciferase expression and luminescence 
emission occurs. Therefore, the reduced emission of luminescence after LPS stimulus 
indicates that BOP6 treatment was able to inhibit NF-кB activation.  
The inhibition of NF-кB activation is an interesting target for treating 
inflammatory diseases because, once activated, NF-кB migrates to the cell nucleus 
and affects the synthesis of important inflammatory proteins, which makes the cells 
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more responsive and combative to infectious agents33. With this, several pro-
inflammatory mediators, membrane proteins and receptors are overexpressed, e.g., 
TNF-α cytokine, which modulates the expression of other cytokines, chemokines and 
proteins, thereby facilitating the influx of neutrophils into the inflammatory focus31.  
Hence, BOP6 seems to be an interesting source of anti-inflammatory 
compounds that act in alternative targets of the inflammatory process reducing NF-kB 
activation, TNF-α release and neutrophil migration. BOP6 may be safer than the 
available drugs and its consumption as a functional food may protect mammal 
organisms from inflammatory and autoimmune conditions. 
3.2. Antifungal effects and mechanism of action 
Overall, fungal infections rarely develop in non-susceptible individuals. For 
an opportunistic fungal infection to establish, there should be some kind of host 
immunosuppression or exposure to a medical procedure, such as transplantation, use 
of indwelling devices and prolonged intensive care unit stays34. While C. albicans is 
the most prevalent species involved in invasive fungal infections, the incidence of 
infections due to non-albicans species is also increasing in the hospital setting35,36. 
Here, BOP6 was tested for its antifungal activity against Candida spp. As 
shown in Table 1, BOP6 showed MIC values ranging from 50 to 100 µg/mL and MFC 
values ranging from 200 to 400 µg/mL on all tested species. Amphotericin B (AmB) 
showed lower MIC and MFC values against all Candida spp., which ranged from 0.25 
to 1.0 µg/mL (Table 1). 
Table 1. Effects of BOP6 and Amphotericin B on Candida spp. viability (MIC and MFC).  
Treatment 
MIC/MFC (µg/mL) 
C. albicans C. tropicalis C. glabrata C. parapsilosis C. krusei 
BOP6 100/200 200/400 100/200 100/200 50/100 
AmB 0.5/1.0 0.5/1.0 0.5/1.0 0.5/1.0 0.25/0.5 
The literature reports that natural products with MIC and MFC values below 
500 µg/mL are considered strong antimicrobials37. Therefore, we next studied the 
deleterious effects of BOP6 on Candida spp. mature biofilms, as described below. 
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It is a consensus that the majority of diseases produced by Candida species 
is associated with biofilm growth38. Biofilms are organized communities of cells under 
the control of signaling molecules which are embedded in an extracellular matrix39. 
Biofilm structures are more complex than planktonic (circulating) cells and thereby 
prevent the penetration of antimicrobial agents, which makes biofilms more resistant 
to treatment40. Therefore, the biofilm organization is a form of protection, encouraging 
symbiotic relationships and allowing survival in hostile environments41, 42. As shown in 
Figure 4, treatment of Candida spp. mature biofilms with BOP6 was as effective as, or 
even better than, that with the isolated antifungal molecule AmB, a gold-standard drug. 
 
Figure 4. Effects of BOP6 on Candida spp. mature biofilms. C. albicans (A), C. tropicalis (B), C. 
parapsilosis (C), C. krusei (D) and C. glabrata (E) biofilms were formed for 24 h and then treated for 4 
h with BOP6 or Amphotericin B (AmB) at MIC and 10xMIC. Surviving mature biofilm cells were plated 
for CFUs. Different letters indicate statistical difference between groups (p<0.05, ANOVA with Tukey’s 
post-test). 
Another important virulence factor of Candida spp. is their capacity to 
adhere to abiotic surfaces and host cells40. The first step for establishment of infection 
is adherence to host tissues40. Here, we tested the effects of BOP6 in preventing or 
mitigating yeast adhesion to human cells. At sub-inhibitory concentrations (lower than 
MIC), treatment with BOP6 reduced the adhesion of Candida spp. cells to human 
keratinocytes (Figure 5). Interestingly, treatment of C. parapsilosis and C. krusei (for 1 
h and 2 h); and C. glabrata (for 2 h) with BOP6 at sub-inhibitory concentrations was 
found to be as effective as that with the isolated gold-standard AmB (Figure 5). 
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Figure 5. Effects of BOP6 on Candida spp. adhesion to Human keratinocytes (HaCat). Human 
keratinocytes were adhered to 96-well plates, inoculated with C. albicans (A), C. tropicalis (B), C. 
parapsilosis (C), C. krusei (D) or C. glabrata (E), and treated with BOP6 or Amphotericin B (AmB). After 
1 h or 2 h, keratinocytes-adhered Candida spp. cells were plated for CFUs. Different letters indicate 
statistical difference between groups (p<0.05, ANOVA with Tukey’s post-test). 
3.3. In vivo toxicity of BOP6 
A preliminary in vivo toxicological evaluation of BOP6 was carried out using 
G. mellonella model. The results showed that at the doses of 3, 1.5 and 0.75 g/Kg, 
BOP6 did not affect larvae survival when compared to the inert vehicle. When 
administered at the highest test dose (6 g/Kg), BOP6 reduced survival only after 20 
hours upon treatment (p < 0.05; Figure 6). These findings suggest that BOP6 may 
have very low toxicity. The literature reports that the findings obtained in G. mellonella 
larvae correlate with those seen in mammal models21. In addition, we note that the 
BOP6 doses injected in the larvae are much higher than the usual propolis intake by 
humans. 
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Figure 6. Effects of BOP6 on Galleria mellonella larvae survival. G. mellonella larvae were treated with 
BOP6 at 0.75, 1.5, 3 and 6 g/Kg or with the vehicle, and their survival was monitored for 60 h (*p<0.05, 
Log-rank Mantel-Cox test). 
3.4. In vivo treatment of C. albicans infection with BOP6 
 Four groups of larvae were used in this assay, of which three were 
inoculated with C. albicans (5x107 cells/mL) and one served as the uninfected control. 
Another control group (infected) treated only with the dilution vehicle (0.9% NaCl) was 
included and showed 100% survival at the end of the experiment. All larvae in the 
infected vehicle-treated group were dead after 42 h. However, the infected BOP6-
treated group (20 mg/Kg) showed 30% survival at the end of the experiment, indicating 
that BOP6 prevented killing, although to a lesser extent. The group treated with 
amphotericin B (50 µg/Kg) – isolated and gold-standard drug – showed 90% survival 
at the end of the experiment (Figure 7). 
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Figure 7. Effects of BOP6 on Galleria mellonella larvae infection by C. albicans. After inoculation with 
C. albicans ATCC 90028 (5x107 cells), larvae were treated with BOP6 (20 mg/Kg), Amphotericin (50 
µg/Kg), or vehicle (0.9% NaCl), and their survival was monitored for 80 h. (p<0.05, Log-rank Mantel-
Cox test). 
BOP6 was able to prevent 30% death in the C. albicans-infected sample. 
This result shows that BOP6 reproduces its in vitro antifungal effects in a more complex 
environment, such as the larval organism. As expected, Amphotericin B promoted the 
survival of 90% of the sample, showing a better survival outcome. This validated model 
provides preliminary information on the toxicity of compounds and infective potential of 
pathogens, while it helps reducing the number of mammals in further scientific 
experimentation. According to the literature, G. mellonella is considered a relevant 
alternative approach for the prospection of new antimicrobial drugs21, 43. 
3.4. Phytochemical analysis of BOP6 
Previously, we determined the chemical profile of seven distinct BOP 
samples, including BOP6. In that occasion, we looked specifically for compounds 
commonly found in propolis by HPLC14. Gallic acid was the only compound identified 
in BOP6. In addition, this organic propolis showed the lowest phenolic content (17.59 
mg GAE/g), and no flavonoids were detected14. Interestingly, these figures are much 
lower than those of other Brazilian propolis types, such as green propolis (120 mg 
GAE/g of total phenolics and 51.9 mg/g of flavonoids)44 and red propolis (232 mg 
GAE/g of total phenolics and 43 mg/g of flavonoids)11. As BOP6 appears to have a 
distinct phytochemical profile, for this study we carried out a refined chemical 
evaluation using the LC–ESI-QTOF-MS technique. The compounds identified in BOP6 
are listed in Table 2. 
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Table 2. Identification of phytochemical compounds in BOP6 by the LC-ESI-QTOF-MS technique (negative mode). 
Compound 
Molecular 
Formula 
Exact 
Mass 
(g/mol) 
RT 
(min.) 
ESI (mV) [M-H]- 
Fragments MS 
(m/z) 
Error 
(ppm) 
Reference 
Chemical 
Structure 
Caffeoyltartaric 
acid 
C13H11O9 312.0482 18.0 35.3 - 88.2 311.0417 
135.0300 (100); 149.0288 
(93); 179.0133 (20) 
-4.8 
(Viacava et 
al., 2018) 
 
3,4-
Dicaffeoylquinic 
acid 
C25H24O12 516.1270 26.7 
40.3 - 
100.8 
515.1159 
135.0305 (100); 161.0066 
(46); 179.0145 (100) 
+6.4 
(Zhang et al., 
2015; Wang 
et al., 2016) 
 
Quercetin C15H10O7 302.0430 45.8 35.0 - 87.6 301.0367 
124.0018 (40); 151.9938 
(100) 227.0444 (31) 
-6.1 
(Falcão et al., 
2013) 
 
Gibberellin A7 C19H22O5 330.1467 88.0 35.7 - 89.3 329.1379 255.1454 (100) +3.0 
MassBank 
(PR020147) 
 
Gibberellin 
A20 
C19H24O5 332.1624 89.8 35.8 - 89.8 331.1524 
257.1618 (6); 301.1453 
(100); 331.1512 (15) 
+6.6 
MassBank 
(PR020157) 
 
Gibberellin A9 C19H24O4 316.16746 96.8 35.4 - 88.4 315.1588 315.1582 (100) +2.7 
MassBank 
(PR020151) 
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Caffeoyltartaric acid generated a precursor ion with 311.0417 (M-H)- at the 
range of 35.3 - 88.2 mV. Some authors described that fragments m/z 149 and m/z 179 
correspond to the deprotonated tartaric and caffeic acids, and that fragment m/z 135 
corresponds to the loss of CO2 (predominant fragment)45, 46. 
Trans-caffeoyltartaric acid was identified in esca-diseased Vitis vinifera 
leaves. The authors reported that the plant starts to increase the production of this 
compound and other phenolic compounds when its leaves are affected by esca 
infection47. Esca disease possesses a complex etiology but is strongly associated with 
fungi infection, particularly by Phaeomoniella chlamydospora, Phaeoacremonium 
minimum, and Fomitiporia mediterranea species48. Therefore, the identification of 
caffeoyltartaric acid and the antifungal properties of BOP6 are consistent with the 
literature findings, since BOP6 is produced under organic conditions and bees may 
collect exudates from plants suffering from fungal infections. We believe that this 
condition may enhance the composition of secondary metabolites in BOP6, including 
cafeic acids derivatives. 
The compound 3,4-dicaffeoylquinic acid (3,4-diCQA) produced the 
precursor ion with 515.1159 (M-H)- at the range of 40.3 - 100.8 mV. It was 
demonstrated that the fragments m/z 135.0305, m/z 161.0066, and m/z 179.0145 
result from the loss of water, caffeic acid and CO2, respectively49. 
A previous study investigated the anti-inflammatory activity of 3,4-DiCQA 
present in the traditional Chinese herbal formula named Kouyanqing Granule, which is 
composed of Flos lonicerae, Radix scrophulariae, Radix ophiopogonis, Radix 
asparagi, and Radix et rhizoma glycyrrhizae. The authors showed that 3,4-DiCQA 
reduced the release of cigarette-stimulated interleukins 1β, 6, 8, and TNF-α in human 
oral keratinocytes50. The compound 3,4-DiCQA, which is also present in Cuscuta 
japonica seeds, inhibited angiotensin I enzymatic activity51 and bronchoalveolar fluid 
leukocytosis in an acute airway inflammation model in mice52. Interestingly, the 
association of 3,4- and 3,5-diCQAs inhibited LPS-induced expression of nitric oxide, 
prostaglandin E2 and cyclooxygenase-2 in RAW 264.7 macrophages via inhibition of  
translocation of p50 and p65 NF-kB subunits53. These results are a strong indicative 
that the presence of 3,4-diCQA in BOP6 might be accountable for the anti-
inflammatory activity observed. 
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Quercetin produced the precursor ion with m/z 301.0367 (M-H)- at the range 
of 35.0 - 87.6 mV. Quercetin is a flavonoid usually detected in vegetables and fruits. 
Numerous propolis samples from Brazil and other countries have quercetin in their 
chemical composition. The anti-inflammatory mechanisms of quercetin are related to 
the TLR4/NF-kB pathway and macrophage polarization54-56. In addition, there is 
scientific evidence on the antifungal properties of quercetin-rich extracts57,58. Isolated 
quercetin was effective against C. albicans in a vulvovaginal candidiasis-murine model, 
and its combination with fluconazole produced a synergistic effect59. Therefore, it is 
possible that quercetin may act synergistically with other compounds present in BOP6 
to produce antifungal and anti-inflammatory effects. 
Gibberellins A7, A20 and A9 were detected in BOP6 samples at the ranges 
of 35.7 - 89.3, 35.8 - 89.8, and 35.4 - 88.4 mV. Gibberellin A7 showed a precursor ion 
with m/z 329.1379 (M-H)- and a majority fragment of m/z 255.1454. Gibberellin A20 
showed a precursor ion with m/z 331.1524 (M-H)- and a majority fragment of m/z 
301.1453 (M-H)-. Gibberellin A9 showed a precursor ion with m/z 315.1588 (M-H)- and 
a majority fragment of m/z 315.1582 (M-H)-. These compounds were identified by 
comparing the fragmentation pattern of each compound with the mass spectra 
database (IDs: PR020147; PR020157; and PR020151). 
Gibberellins (GA) are a large group of tetracyclic diterpenoid carboxylic 
acids, which serve as important hormones for plant growth60, 61. While facing abiotic 
stress conditions, such as drought, shading, flooding or low temperature, GA modulate 
the plant cell proliferation, elongation, and promote developmental phase transitions to 
overcome these situations60, 61. GA may also act inhibiting plant growth so that all 
resources are focused on stress survival60, 62. In nature, GA can also be produced by 
fungal species, but their synthesis follows a different route63. 
As with trans-caffeoyltartaric acid, which is overproduced under fungal 
infections, the synthesis of GA may be a result of its organic source, since BOP6-
producing beehives are located in an environment that is expected to have much more 
abiotic stress than that of non-organic conventional propolis. Therefore, we assume 
that there is a greater production of gibberellins in plants under organic growth 
conditions, and that such a higher synthesis of gibberellins is reflected on the chemical 
composition of BOP6. 
40 
 
Because of the effects of GA on plant growth and stress resistance, 
especially of gibberellin GA3, some producers utilize commercial products containing 
these compounds to enhance fruits, vegetables and cereals63, 64. However, we note 
that BOP6 production is strictly organic and that exogenous crop additives are not 
present in at least 2 miles from the apiaries. Therefore, we can infer that the GA content 
in BOP6 is due to the natural plant production in response to stressful organic growth 
conditions. 
There are no studies in the literature on the antifungal activity of GA, but 
some authors have reported anti-inflammatory effects of these molecules, especially 
GA3. GA3 seems to play important roles in both plant (stress-survival) and mammalian 
cells. Curiously, the A20 structure [TNFAIP3 (TNF-α-induced protein 3)] is a target for 
GA3 that is present in both plant and mammalian cells65. In plants, A20-like zinc finger 
proteins are activated by GA3 to improve stress response66. In mammalian cells 
stimulated with E. coli LPS, A20 induction by GA3 attenuates inflammation in airway 
epithelial cells (reduction of IL-6 and IL-8 release) via NF-κB and IκBα inhibition65.  
There are no reports on the antifungal and anti-inflammatory properties of 
GA7, GA9 and GA20, which were identified in BOP6. However, these GA display 
chemical similarity (Table 2) and might also be responsible for the biological effects of 
BOP6.  
To the best of our knowledge, there are no reports on the presence of GA 
in propolis composition. Therefore, these molecules could be used as chemical 
markers for organic propolis quality control. Further research should provide an in-
depth analysis of the chemical profile of propolis produced under organic conditions.  
Our findings suggest that the compounds identified in BOP6 crude extract 
(Table 2) are responsible for the anti-inflammatory and antifungal effects of this 
peculiar propolis sample. However, it is also likely that these compounds act together 
synergistically or additively to produce biological effects. The synergistic and additive 
effects of natural compounds have been studied by many authors, with a focus on the 
biological effects of different combinations of isolated natural compounds. For 
instance, caffeic acid and quercetin from pepper (Capsicum annuum L.) act additively 
and synergistically to produce antimicrobial effects against clinical strains of 
Staphylococcus aureus67 and Escherichia coli strains68. Therefore, synergistic or 
additive effects are expected to be observed among BOP6 compounds. 
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3.5. Conclusion 
In conclusion, our findings demonstrate that BOP6 has strong anti-
inflammatory properties and acts by reducing NF-кB activation and TNF-α release in 
macrophages, ultimately reducing neutrophil influx into the inflammatory focus. BOP6 
was found to inhibit planktonic and biofilm Candida spp. growth and yeast adhesion to 
human keratinocytes. BOP6 demonstrated significantly low toxicity in Galleria 
melonella larvae at antifungal doses. These effects may be mediated by the phenolic 
compounds caffeoyltartaric acid, 3,4-Dicaffeoylquinic acid and quercetin and the 
terpenoids gibberellin A7, A9 and A20. The identification of these compounds is an 
important finding and shows that the organically produced Brazilian organic propolis 
profile 6 (BOP6) may be a safe and interesting source of bioactive molecules and 
functional food. 
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ABSTRACT 
Gibberillins (GA) are terpenoids that serve as important plant hormones by 
acting as modulators of growth and responses against injuries and parasitism. 
Previously, we have showed that GA are present in the Brazilian organic propolis 
(BOP), an unexplored organic propolis with anti-inflammatory and antifungal effects. 
Here, our goal was to test if the isolated GA A4 (GA4) and GA A7 (GA7) present 
antifungal and anti-inflammatory effects and may be responsible for the interesting 
BOP effects. It was also our goal to verify the GA4 and GA7 antioxidant effects and 
toxicity profile. Our data showed that GA4 reduced the NF-кB activation on 
macrophages. GA7 presented antifungal effect with low MIC/MBC values (94 and 188 
nM, respectively) and anti-biofilm properties against Candida albicans strain. GA4 and 
GA7 also presented peroxyl radical scavenging properties and both molecules were 
non-toxic on the in vivo Galleria mellonella model, did not reducing the larvae survival 
in massive doses. These data lead us to conclude that GA4 and GA7 present 
interesting anti-inflammatory, antifungal and antioxidant effects with non-toxic profile 
on G. mellonella model. 
Keywords: Gibberillin A4, Gibberillin A7, propolis, macrophages, neutrophils, Candida 
albicans, antifungal, anti-inflammatory, NF-кB Galleria mellonella, toxicicty, natural 
products, antioxidant, free radicals, Brazil. 
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INTRODUCTION 
Propolis can be defined as a resin collected by bees from the exudates of 
plants surrounding the beehive (Ghisalberti, 1979). Bees use the propolis for many 
purposes, such as isolate the hive against rain and wind; to protect the hive and bee 
products (honey, pollen and royal jelly, for instance) against bacterial, viral and fungal 
infections; and even to mummify the body of killed invaders (Bankova et al., 2000). 
Observing the benefits of propolis to the bee society, humans are 
consuming propolis products since ancient times and many interesting biologic 
properties were reported to these natural products (Sforcin & Bankova, 2011). 
Likewise, many bioactive molecules were isolated from propolis samples, such as 
apigenin and tt-farnesol (Koo et al., 2003); vestitol and neovestitol (Silva et al., 2008); 
CAPE and artepillin C (Ahn et al., 2007) among others. Propolis crude extracts, purified 
fractions and isolated molecules were reported to have antibacterial (da Cunha et al., 
2019), antifungal (Nani et al., 2019), antibiofilm (Bueno-Silva et al., 2013), anti-
inflammatory (Franchin et al., 2013), anticancer (Alencar et al., 2007), and other 
interesting biologic properties. 
Therefore, propolis became an important product that is used to prevent and 
treat many diseases. In general, propolis products are produced with propolis samples 
from hives located in human-controlled environments, with specific plants surrounding 
the hive, water and aliments to the bees. In this scenario, bees produce propolis from 
specific sources, such as the poplar propolis, which is collected by bees from Poplar 
trees (Populus L., Salicaceae Family) (Park et al., 2002; Bankova, 2005); the green 
propolis which is collected by bees from Baccharis dracunculifolia buches (Park et al., 
2002); and the red propolis which is collected from Dalbergia ecastophyllum bushes 
(Alencar et al., 2007; Silva et al., 2008).  
Hence, the hives are directly affected by the surrounding human activity, 
either by the owners of the apiary or even by neighboring properties. In some cases, 
propolis may be contaminated with soil additives, metals and pesticides (Finger et al., 
2014; Umsza-Guez et al., 2019).  
Likewise, Brazil and other countries started to produce propolis on organic 
environments. To obtain worldwide certificates, these apiaries need to attend to a 
rigorous list of prerequisites, such as to be located at a minimal distance from intensive 
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agricultural properties and to remain the bees to adapt and collect resources from an 
untouched forest in a natural way.  
This is the case of the Brazilian Organic Propolis (BOP), which is produced 
under strict organic conditions according to international legislations in Paraná and 
Santa Catarina states of South Brazil. This kind of propolis is little scientifically 
evaluated, and our previous studies showed that BOP present huge chemical 
variability and interesting biological properties (Tiveron et al., 2016). 
BOP may be grouped in seven chemical profiles; and most of them present 
antibacterial and antioxidant activities (Tiveron et al., 2016). Interestingly, the BOP 
profile 6 (BOP6) presented insignificant antibacterial and antioxidant activities, but was 
the only chemical profile with anti-inflammatory effects (Tiveron et al., 2016). More 
recently, we refined the study of effects and anti-inflammatory mechanisms of action 
of BOP6 and results showed that BOP6 is a promising and useful source of anti-
inflammatory compounds (Nani et al., 2019). Also, we showed that BOP6 have 
antifungal activities and present gibberillins (GA) on its chemical profile (Nani et al., 
2019). 
Our previous report was the first scientific report showing GA on a propolis 
composition. GA are a large group of tetracyclic diterpenoid carboxylic acids, which 
serve as important plant hormones that act modulating plant growth (Sponsel & 
Hedden, 2004; Colebrook et al., 2014). Our findings points out that the presence of GA 
on BOP is related to its organic condition, since the GA are strongly correlated to the 
modulation responses of many plants to biotic and abiotic stress (Colebrook et al., 
2014). This statement is plausible since BOP is collected by bees of plants under an 
environment that is expected to be more challenger for the plants in many aspects, 
such as fungal infections, parasitism and climate changes, since these plants are at 
the mercy of the wild Atlantic Rain Forest environment in contrast to other propolis that 
are produced under non-organic locations. In brief, we inferred that the plants 
surrounding the beehive produce GA in response to the environment stress and the 
presence of these molecules is directly reflected in the propolis composition. 
However, few is known about the anti-inflammatory and antifungal effects 
of the GA. The little knowledge about the effects of GA in mammals is related to the 
GA A3 (Reihill et al., 2016), but none information regarding the anti-inflammatory and 
antifungal effects of other GA are reported. Therefore, the objective of the present 
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article is to confirm if the isolated commercial obtained GA A4 and A7 compounds 
present anti-inflammatory and antifungal effects; and to verify these GA antioxidant 
properties and toxic profile. 
MATERIAL AND METHODS  
 
REAGENTS 
GA4 and GA7 were purchased from Santa Cruz biotechnology (EUA).  
Amphotericin B (AmB), RPMI 1640, Triton-X, Escherichia coli B4 LPS, Fetal Bovine 
Serum, dextran, penicillin, DMSO (dimethyl sulfoxide), MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) and glutamine were purchased from Sigma-
Aldrich (U.S.A.).  
 
MACROPHAGES INFLAMMATION ASSAYS  
 
• Culture conditions and in vitro viability assay (MTT) 
To test the GA4 and GA7 in vitro anti-inflammatory effects, we used RAW 
264.7 macrophages stably transfected with NF-κB luciferase reporter gene. Cells were 
cultured in RPMI supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin 
and 2 mM L-glutamine, incubated at 37°C in 5% CO2 atmosphere. Initially, the effects 
of GA4 and GA7 on macrophage viability were determined by the MTT method. Briefly, 
cells were seeded onto 96-well plates (2 x 105 cells/well) and incubated overnight in 
supplemented RPMI. The cells were treated with GA4 and GA7 at 0.3, 3, 10 and 30 
µM and incubated in plain RPMI for 24 h at 37°C in 5% CO2. Later, the supernatant 
was discarded and 0.3 mg/mL MTT in plain RPMI was added to the wells and 
incubated for 3 h. The supernatant was discarded and 200 µL of DMSO was added to 
each well. The absorbance of the lysates was measured at 570 nm in a microplate 
reader. The assays were carried out in quadruplicates of three independent 
experiments. The results were expressed as viability percentage in relation to the 
negative control group. 
• In vitro NF-кB activation assays 
The RAW 264.7 macrophages (3 x 105 cells/well) were adhered to 24-well 
plates in supplemented RPMI overnight. The cells were incubated in the presence of 
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the GA4 and GA7 at 0.3, 3, 10 and 30 µM in plain RPMI for 30 min at 37°C in 5% CO2. 
Afterwards, the cells were stimulated with LPS (10 ng/mL final concentration) for 4 h; 
supernatant was discarded; and remaining adhered cells were used to determine the 
NF-кB activation status. Briefly, macrophages were lysed with Tris-NaCl-Tween buffer 
and 10 µL of the lysate was mixed with 25 µL of the luciferase assay reagent containing 
luciferin in a 96-well opaque plate. Luminescence was quantified in a microplate reader 
(Molecular Devices). All assays were carried out in quadruplicates of three 
independent experiments. The results are expressed as relative luminescent units (NF-
кB activation level) in relation to the stimulated untreated control group. 
ANTIFUNGAL ASSAYS  
• Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal 
Concentration (MFC) assays 
GA4 and GA7 antifungal activities were evaluated against Candida albicans 
(MYA 2876). The Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal 
Concentration (MFC) were determined by the microdilution method according to CLSI 
protocols (CLSI, 2002). Briefly, an inoculum (103 UFC/mL) was prepared in RPMI 
medium supplemented with L-glutamine (2 mM), glucose (2%) and MOPS buffer (final 
pH - 7.0). GA4 and GA7 were diluted in RPMI medium and tested at concentrations 
ranging from 2.9 to 188 mM. Amphotericin B (AmB) was used as a positive gold 
standard control at concentrations ranging from 30 to 2 mM. The plates with the inocula 
and treatments were incubated statically for 24 h. The MIC was determined visually as 
the lowest concentration of the drug that did not produce any visual turbidity in the 
wells. Aliquots from the wells with no visual fungal growth were plated onto SDA and 
incubated for 24 h in aerobic atmosphere. The MFC was defined as the lowest 
concentration of the subculture at which no visible growth was observed on solid 
media. The assays were carried out in triplicates of three independent experiments. 
 
• Mature biofilm assay 
C. albicans biofilm was formed in 96 well plates by adding 200 μL of 
inoculum (108 cells/mL) in YNB. The plates were incubated statically for 24 h at 37°C 
in aerobic atmosphere for mature biofilm formation. The supernatant was discarded, 
and the wells were washed to remove non-adhered cells. GA4, GA7 or AmB (positive 
gold standard) were prepared in YNB at concentrations two-fold the MIC value, or ten-
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fold higher (AmB 2x MIC = 1.1 mM and 10x MIC = 5.4 mM; GA7 2x MIC = 188 mM 
and 10x MIC = 940 mM). Mature biofilms were treated for 24 hours at 37°C in aerobic 
atmosphere. The supernatants were discarded, and the wells were washed to remove 
non-adhered or killed cells. The biofilms were homogenized, serially diluted and plated 
for colony-forming units (CFUs) onto SDA. The plates were incubated at 37°C for 24 h 
in aerobic atmosphere and colonies were counted. The assays were carried out in 
triplicates of three independent experiments (Sardi et al., 2017). The results are 
expressed as percent survival in relation to the untreated group. 
REACTIVE OXYGEN SPECIES (ROS) SCAVENGING ASSAYS 
• Peroxyl radical scavenging assay (ORAC - ROO•) 
Peroxyl radical (ROO•) scavenging activity was determined according to 
Melo and colleagues (2015). Briefly, aliquots of 30 μL of the GA4 and GA7 
(concentrations ranged from 23 to 727 mM); 60 μL fluorescein disodium (508 nM); and 
110 μL of AAPH (76 mM) were transferred to a microplate. The solutions were diluted 
with 75 mM potassium phosphate buffer (pH 7.4), which was used as blank. The 
reaction was performed at 37°C and the absorbance of the samples was measured 
every minute for 2 h at 485 (excitation) and 528 (emission) nm, using a microplate 
reader SpectraMax1 M3. Trolox was used as standard at concentrations ranging from 
12.5 to 400 μM and the results were expressed as μmol Trolox equivalents per mg of 
GA4 or GA7 (μmol TE/mg) (Tiveron et al., 2016). 
• Superoxide anion (O2• -) 
Superoxide anion (O2•-) scavenging activity was determined according to 
Gomes and colleagues (2007) and Chisté and colleagues (2011). Briefly, to obtain a 
final volume of 300 µL the following substances were mixture: NADH (166 µM); NBT 
(107.5 µM); GA4 or GA7 (concentrations ranged from 23 to 727 mM); PMS (2.7 µM); 
and the diluent potassium phosphate buffer (19 µM, pH 7.4). The assay was conducted 
at 25 °C and after 5 min the absorbance was measured at 560 nm. Potassium 
phosphate buffer was used as blank. Trolox was used as standard at concentrations 
ranging from 12.5 to 400 μM and the results were expressed as EC50, which means 
the mean concentration of GA4 or GA7 required to quench 50% of the superoxide 
radicals (Tiveron et al., 2016). 
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• Hypochlorous acid (HOCl) 
Hypochlorous acid (HOCl) scavenging activity was determined according to 
Gomes and colleagues (2007) and Chisté and colleagues (2011). Briefly, solutions of 
the GA4 or GA7 (concentrations ranged from 23 to 727 mM); were homogenized with 
phosphate buffer (100 mM; pH 7.4); DHR (1.25 µM diluted on 1.15 mM 
dimethylformamide); and HOCl (5 µM; diluted on 1% NaOCl solution, with final pH 
adjusted to 6.2 with H2SO4), to complete a final volume of 300 µL on microplates. 
Fluorescence was measured immediately in a microplate reader (Molecular Devices, 
LLC, Sunnyvale, CA, USA) using the emission wavelength of 528 ± 20 nm with 
excitation at 485 ± 20 nm. The results were expressed as IC50, mean concentration of 
GA4 or GA7 (Tiveron et al., 2016). 
• Nitrogen species (RNS) 
The nitric oxide (NO•) scavenging activity was determined according to 
Czerwińska, Kiss, & Naruszewicz (2012). Briefly, 50 μL of GA4 or GA7 solution 
(concentrations ranged from 23 to 727 mM) were disposed on a 96-well microplate 
with 50 μL of SNP solution (10 mM), 50 μL phosphate buffer (100 mM; pH 7.4) and 50 
μL of DAF solution (25 μM). Fluorescence was measured in a microplate reader 
(Molecular Devices, LLC, Sunnyvale, CA, USA) with excitation of 495 nm and emission 
of 515 nm. Measurements were made over a 120 min period at 5 min intervals. The 
results were expressed as IC50 (μg/mL) of the GA4 and GA7 (Melo et al., 2015). 
IN VIVO TOXICITY ASSAY  
To verify the in vivo toxicity of GA4 and GA7, we carried out a Galleria 
mellonella assay. G. mellonella larvae were grown at 37 °C and those Larvae with no 
signs of melanization and weighing 200 to 300 mg were randomly selected to form the 
experimental groups (n = 20). Each group received 10 μL of GA4 or GA7(up to 12,5 
g/Kg) or saline solution (control group) into the larva hemocoel via the last left proleg. 
The injection occurred using a 10 μL Hamilton syringe. All groups were incubated at 
37 °C, and larvae survival was monitored at selected intervals for up to 72 h. The larvae 
showing high melanization and absence of movements upon touch were counted as 
dead (Freires et al., 2016). 
STATISTICAL ANALYSIS 
Data homoscedasticity and normality were checked and were normally 
distributed. Therefore, data containing more than two groups were analyzed by one-
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way analysis of variance (ANOVA), followed by Tukey’s post hoc test (macrophage 
NF-κB activation and biofilm assay). Data containing two groups (MTT) was analyzed 
by unpaired Student T test. Percent survival of G. mellonella larvae was compared 
using the log-rank Mantel−Cox test. In all experiments, the sample size was calculated 
a priori for each assay providing 80% power, considering 5% α error. In all experiments, 
the significance level was set at 5%, and the analysis was performed using GraphPad 
Prism version 6.0 for Windows (GraphPad Software, Inc., San Diego, CA, U.S.A.). 
RESULTS AND DISCUSSION 
Here we report the anti-inflammatory and antifungal effects of the isolated 
molecules gibberellin A4 (GA4) and gibberellin A7 (GA7). Briefly, our results show that 
GA4 presented interesting anti-inflammatory effects on macrophages, reducing the 
NF-кB activation without changing the cell ciability. GA7 presented antifungal effect 
with low MIC and MBC values and anti-biofilm properties against C. albicans strain. 
GA4 and GA7 also presented peroxyl radical scavenging properties and both 
molecules presented a favorable toxic profile on the in vivo G. mellonella model, didn’t 
reducing the larvae survival in massive doses. Results are detailed and discussed 
below. 
• Anti-inflammatory effects 
Figure 1 shows the anti-inflammatory effects of GA4 and GA7 on RAW 
264.7 macrophages. Treatments occurred on concentrations below 30 µM, since this 
was the higher non-toxic concentration to cells measured by MTT method (Figure 1 B 
and D; p > 0.05; unpaired T test). After non-toxic treatments, cells were stimulated with 
LPS at 10 ng/mL and NF-кB activation was determined by the luminescence assay. 
LPS was able to increase the NF-кB activation in the order of 10 times and GA4 
promoted 32% of reduction of NF-кB activation after LPS stimulus at 30 µM (Figure 1 
A; p < 0.05; ANOVA and Tukey). GA7 was not effective in reducing the NF-кB 
activation at tested concentrations after 10 times increase with LPS stimulus (Figure 1 
C; p > 0.05; ANOVA and Tukey). 
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Figure 1. GA4 have anti-inflammatory properties by reducing the NF-кB activation 
without reducing the macrophage viability. RAW 264.7 macrophages were treated with 
GA4 and GA7 at 3, 10 and 30 µM and were stimulated with LPS at 10 ng/mL. NF-кB activation 
was evaluated by luminescence assay (A and C). Viability was evaluated by MTT method (B 
and D). Difference letters indicate statistically significant differences measured by ANOVA and 
Tukey test (A and C) or unpaired T test (B and D). 
 
The NF-кB is a well consolidated intracellular pathway that is important to 
numerous vital processes, especially inflammation and immunity responses (Taniguchi 
& Karin, 2018). These responses are crucial to human life, but the NF-кB route is also 
related to chronic diseases, such as cancer (Laveti et al., 2013), periodontal disease 
(Kurgan & Kantarci, 2018) and rheumatoid arthritis (Jimi et al., 2019). Therefore, it is 
consolidated that controlling the exacerbated NF-кB activation is an interesting 
approach to treat inflammatory diseases (Chen et al., 2018). 
Many stimuli are able to trigger and starts the NF-кB pathway, some of them 
are externus to our body, such as the Gram-negative bacteria lipopolysaccharide 
(LPS). However, internal mediators, such as the TNF-α and IL1β, are also able to 
activate the NF-кB route (Kawasaki & Kawai, 2014). Once activated, the NF-кB migrate 
to the cell nucleus and alter the gene expression, guaranteeing to the cell tools to deal 
with infectious agents (Chen et al., 2018). The macrophages are key cells in these 
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processes, since they signal and recruit other cell to the inflammatory focus, such as 
the neutrophil in acute inflammatory phase (Wright et al., 2010). However, in the 
occasion of chronic inflammatory diseases, the NF-кB inflammatory response starts to 
be exacerbated and promote more damage than benefits.   
Therefore, the GA4 ability to reduce the NF-кB activation is desirable and is 
in accordance with its source, the BOP6. Our previous study showed that the BOP6 
crude extract was able to reduce the NF-кB activation in the order of 78% (Nani et al., 
2019). Observing these results, it seems that the BOP6 effect is more intense than the 
GA4 effect, however, it is crucial to notice that the crude extract was effective in much 
higher concentration (10 µg/mL) than the GA4 (30 µM). Therefore, we can infer that 
the GA4 present in the BOP6 sample may be responsible for its anti-inflammatory 
activities; however, it is possible that other molecules may act synergistically with GA4 
and these molecules, together, are responsible for the BOP6 anti-inflammatory activity. 
• Antifungal effects  
Table 1 show the MIC and MBC results obtained with GA4, GA7 and 
Amphotericin B (AmB) against the fungal specie Candida albicans. Results showed 
that GA4 was not effective inhibiting the growth (MIC) or killing (MFC) the fungi cells at 
tested concentrations. However, GA7 was effective, with MIC and MFC values of 94 
and 188 mM, respectively. The gold standard AmB MIC and MFC values were lower 
than GA7 (0.54 and 1.16 mM).  
 
Table 1. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) 
of Amphotericin B, Gibberillin A4 and Gibberillin A7 against C.  Albicans (MYA 2876) 
Treatment MIC (mM) MFC (mM) 
Amphotericin B 0.54 1.16 
Gibberillin A4 > 188 > 188 
Gibberillin A7 94 188 
 
Considering that GA7 obtained interesting MIC numbers against C. albicans 
planktonic cells, we conducted a more complex assay to test the GA7 ability to reduce 
the mature viable biofilm cells and results are shown at figure 2. Considering the high 
complexity and difficult to reduce viable cells on mature biofilms when compared to 
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planktonic cells, we used higher concentrations (2 and 10 times higher than MIC 
values) of GA7 and AmB in this assay. 
 
Figure 2. GA7 reduce the C. albicans biofilm formation at 10 times MIC (940 mM). C. 
albicans biofilms was formed and treated with GA7 or AmB at 2- or 10-times higher MIC 
concentration, results are shown as FCU/mL. Difference letters indicate statistically significant 
differences measured by ANOVA and Tukey tests (p < 0.05). 
 
Thus, GA7 was effective reducing the viable biofilm cells in both tested 
concentrations. At 2 times MIC (188 mM), GA7 reduced the viable biofilm cells in the 
order of 11% and at 10 times MIC (940 mM) GA7 reduced it at the order of 30% (Figure 
4). Interestingly, GA7 at 10 times MIC obtained a similar result when compared to AmB, 
the gold standard at this assay, at 2 times MIC concentration (at 1.1 mM AmB reduced 
29.7% of viable biofilm cells). However, the gold standard produced the higher result 
of this assay at 10 times MIC concentration (5.4 mM) reducing the viable biofilm cells 
in the order of 68%, being more effective than GA7 in all tested concentrations (Figure 
2). 
Fungal infections play an important role in general mammal infectious 
diseases (Sardi et al., 2013). Among these infections, C. albicans has great 
importance, since it colonizes most of healthy individuals and may become a pathogen 
that cause severe, and often fatal, bloodstream infections (Lohse et al., 2018). Fungal 
organisms are considered opportunistic pathogens, because they have the ability to 
enter in the bloodstream and to adhere to solid surfaces forming biofilms when the host 
immunity is weakened (Sardi et al., 2013).  
Biofilms are complex forms of cellular organization between microorganism 
and are an environment that protects the biofilm-resident cells against immune 
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responses and antimicrobial treatments (Sardi et al., 2013). Therefore, the ability to 
reduce the viable cells on a mature biofilm structure is very desirable to isolated 
molecules and natural products. 
Our previous results showed that BOP6 presented extraordinary anti-
candida effects, by acting in multiple targets of infection: reducing the planktonic and 
biofilm Candida cells viability; reducing the adherence of fungal species to human cells; 
and increasing the survival of G. mellonella larvae under infection by C. albicans (Nani 
et al., 2019). These effects, combined to the identification of GA7 in BOP6 (Nani et al., 
2019), lead us to hypothesize that GA7 may be responsible for the antifungal BOP6 
effects. However, similar to the anti-inflammatory phenomenon discussed in the 
previous session, other molecules may act synergistically with GA to guarantee the 
antibiofilm properties of BOP6.   
It is interesting that BOP6 present GA with both anti-inflammatory and 
antifungal effects. These data lead us to infer that the consumption of BOP6 products 
may protect human and mammal subjects against inflammatory and fungal events. 
Considering these data and the current human habit to consume propolis products, it 
is of great interest and ethical to initiate clinical trials with BOP6 products to confirm 
this theory.  
• Antioxidant effects 
Table 2 show the results obtained with GA4 and GA7 in antioxidant assays. 
GA4 and GA7 presented scavenging activity against the ROO● radical (0.22 ± 0.05 
and 0.61 ± 0.04 TE/mg, respectively). However, both GA4 and GA7 were ineffective to 
scavenge the radicals superoxide anion (O2• -); hypochlorous acid (HOCl) and nitrogen 
species (RNS – Table 2).  
Table 2. Antioxidant (scavenging activity) of GA4 and GA7 against the radicals peroxyl (ROO•); 
superoxide anion (O2• -); hypochlorous acid (HOCl) and nitrogen species (RNS). 
 
Treatment ROO•  O2• - HOCl NO• 
 μmol (TE/mg) IC50 (μg/mL) IC50 (μg/mL) IC50 (μg/mL) 
GA4 0.22 ± 0.05 un un un 
GA7 0.61 ± 0.04 un un un 
un = undetected 
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In general, the scavenging capacity of GA4 and GA7 results are as 
expected, since BOP6 obtained low or undetected effects in our previous report 
(Tiveron et al., 2016). Among all BOP profiles, the BOP6 was the profile with the lowest 
antioxidant capacity, while BOP profile 4 was the BOP sample with highest antioxidant 
activity.  
Besides the low antioxidant effects of BOP6, we hypothesized that the 
compounds GA4 and GA7 may present more interesting effects, since they were 
tested as isolated treatments and with probably higher concentration than the 
concentration of these compounds in BOP6. Moreover, while existing a possible 
positive and synergistic action of GA and other BOP6 molecules, resulting in anti-
inflammatory and antifungal effects, it is always possible that a negative synergistic 
effect may occur. In this scenario, the presence of other molecules may reduce or 
mask the effects of an isolated molecule, however, this seems not to occur with GA in 
BOP6 samples. 
It is interesting notice that the anti-inflammatory effect of GA4 occur 
otherwise its low antioxidant effect, since some anti-inflammatory products present this 
property secondary to the antioxidant effect. Likewise, a natural product or isolated 
molecule may reduce the production of free radicals by having antioxidant effect, and, 
in a dependent way, the anti-inflammatory effect occur, since most free radicals can 
start inflammatory pathways (Khansari et al., 2009). Therefore, we can assume that 
GA4 anti-inflammatory effects are mainly due to its direct actions on macrophage cells 
through the NF-кB pathway. 
• In vivo toxicity   
Figure 3 A and B show the results obtained with the G. mellonella larvae 
toxicity assay. GA4 and GA7 did not reduced the larvae survival in all tested doses 
until 72 hours of observation. Control group (saline solution) obtained the same result. 
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Figure 3. GA4 and GA7 do not reduce the G. mellonella larvae survival in all tested 
doses. G. mellonella larvae were randomly selected and were treated with GA4, GA7 (0.63, 
1.25, 2.5, 5, and 10 M/Kg doses) or saline solution (negative control). Survival was observed 
until 72 hours after treatments. All larvae survived to treatments until 72 hours, therefore, 
survival lines are overlapping on figures A and B.  
 
This data is very interesting and represents that GA4 and GA7 may be safe 
molecules. It is important to highlight that the solutions injected in the larvae were at 
least 10 times higher than the anti-inflammatory (GA4) and antifungal (GA7) 
concentrations obtained in the present study; and that G. mellonella model is a low 
cost, ethic and reliable method to preliminary verify the toxicity of new drugs and 
natural products (Freires et al., 2016). 
CONCLUSION 
GA4 and GA7 present anti-inflammatory and antifungal activites. GA4 
present anti-inflammatory properties by reducing the NF-кB on macrophages while 
GA7 present antifungal effects against C. albicans. Both molecules are able to 
scavenge the free radical ROO●. The G. mellonella in vivo model showed that GA4 
and GA7 are safety treatments. Therefore, our results confirm that BOP6 effects are 
in part produced by the presence of GA on its composition. 
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3 Discussão 
De forma geral, os dados apresentados nesta tese são indicativos de que 
a PO6 possui atividades anti-inflamatórias e antifúngicas de interesse para medicina 
e odontologia. Além disso os achados mostram que a PO6 é uma própolis com 
composição fitoquímica diferenciada, sendo este o primeiro relato da presença de 
giberilinas em uma amostra de própolis.  
A definição de própolis e o papel das abelhas em sua formação são 
assuntos muito debatidos entre pesquisadores que trabalham com própolis. Já foram 
demonstradas a presença de proteínas salivares de abelhas em amostras de própolis, 
o que sinaliza um papel de sintetizadoras de compostos presentes em própolis. 
Entretanto, tais compostos são minoritários e muitos estudos mostram que a 
composição química majoritária de própolis de diversas regiões do mundo são muito 
próximas da composição química de árvores que localizam-se próximas as colmeias 
(Park et al., 2002; Trusheva et al., 2006; Silva et al., 2008). Assim, entende-se que as 
abelhas desempenham um papel de coletoras de resinas, mas que tais resinas são 
produzidas pela vegetação que se localiza em torno da colmeia. 
Os resultados apresentados nos artigos 1 e 2 desta tese, em conjunto com 
dados reportados por nosso grupo de pesquisa anteriormente (Tiveron et al., 2016), 
mostram que a biodiversidade da Mata Atlântica nativa é refletida na composição 
química da PO. Tal conclusão é embasada pela grande variabilidade química notada 
em amostras dos diferentes perfis da PO e a presença de compostos nunca antes 
encontrados em amostras de própolis (GA7, GA9 e GA20). Dados ainda não 
publicados também apontam para a presença de lignanas e seus precursores em 
amostras da PO perfil 1 (PO1), compostos estes que também não foram identificados 
até então em amostras de própolis. 
A identificação das origens botânicas da própolis de Álamo, própolis verde 
e própolis vermelha, foram realizadas pelo acompanhamento das abelhas 
colheitadeiras até as respectivas árvores fonte de resina e comparação direta entre a 
resina coletada da árvore e da própolis coletada da colmeia. Nestes casos, os perfis 
cromatográficos entre as amostras eram muito semelhantes, levando os 
pesquisadores a interessante conclusão sobre a origem botânica destas amostras de 
própolis (Park et al., 2002; Silva et al., 2008). 
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 Entretanto, tal método não é uma alternativa para identificação da origem 
botânica da PO. Os apicultores que nos forneceram as amostras de PO relatam a 
dificuldade de identificar as árvores que servem de fonte para formação da própolis, 
uma vez que a floresta que circunda os apiários é densa e possui árvores de copas 
altas, chegando a alturas maiores do que 20 metros. Tais características tornam 
inviável o acompanhamento das abelhas até as árvores fonte de resinas. Assim, a 
origem botânica da PO é ainda não-identificada e é um desafio que deve ser vencido 
em pesquisas futuras. 
Uma alternativa que pode ajudar na identificação das origens botânicas da 
PO é a bioprospecção bioguiada. Nesta abordagem, uma amostra de alta 
complexidade química pode ser separada em frações e subfrações de menor 
complexidade de forma sucessiva, até que se obtenha um número reduzido de 
moléculas e, finalmente, uma molécula isolada. 
A escolha das frações e subfrações que serão novamente separadas no 
método da bioprospecção bioguiada pode ser realizada de acordo com as 
características biológicas desejáveis destas amostras, como por exemplo, suas 
propriedades anti-inflamatórias, antimicrobianas e antioxidantes. Assim, o resultado 
final do estudo de bioprospecção pode gerar moléculas de grande interesse para a 
medicina e odontologia, como já ocorreu com as moléculas: artepelim C (Ahn et al., 
2007), CAPE (Bezerra et al., 2012), apigenina e tt-farnesol (Koo et al., 2003), vestitol 
e neovestitol (Bueno-Silva et al., 2013) e 4-fenil cumarina (da Cunha et al., 2019). 
Além de serem protótipos de novos fármacos, tais moléculas podem ser 
usadas como marcadores químicos da amostra de própolis inicial e empregadas como 
identidades de rastreamento da origem daquela propolis. Em amostras de própolis 
verde, por exemplo, é esperado que se identifique o composto Artepelin C (Paulino et 
al., 2008) e os compostos vestitol e neovestitol são comumente encontrados em 
amostras de própolis vermelha (Bueno-Silva et al., 2013). Assim, é interessante obter 
informações sobre a composição fitoquímica da PO6 bem como as atividades 
biológicas de seus compostos. 
A figura 1 do anexo 5 mostra o cromatograma obtido com a injeção da PO6 
na análise de espectrometria de massas de alta resolução. De forma geral, o 
cromatograma aponta que a PO6 apresenta em sua composição um elevado número 
de picos. Ao todo, 124 picos foram detectados, dos quais 6 foram identificados (os 
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picos 26, 37, 56, 97, 102 e 113; representam as moléculas ácido cafeoiltartárico, ácido 
3,4 dicafeoilquínico, quercetina, GA7, GA20 e GA9, respectivamente). É notável que 
os compostos ácido 3,4 dicafeoilquínico, quercetina e as GA7 e GA9 apresentam-se 
com maior intensidade de sinal, podendo ser considerados moléculas de maior 
importância dentro da amostra. 
A bioprospecção da PO6 foi realizada por fracionamento por polaridade 
utilizando-se 6 solventes (hexano, diclorometano, acetato de etila, acetona, metanol e 
água). Das frações obtidas, a fração hexânica (FHe) foi considerada a fração com 
maior pureza química e atividade inibidora da ativação do NF-кB. A análise da FHe 
por HPLC-DAD está apresentada na figura 2 do anexo 5, que mostra que a FHe 
apresenta um número reduzido de picos quando comparada ao cromatograma do 
extrato bruto da PO6. Além disso, o cromatograma mostra que a FHe tem um perfil 
altamente lipossolúvel, concentrando os picos que eluem no final da corrida. 
A avaliação da atividade anti-inflamatória da FHe da PO6 está demonstrada 
na figura 3 do anexo 5. De forma interessante, os resultados obtidos mostram que a 
FHe possui atividade semelhante a molécula isolada dexametasona, que foi 
empregada no experimento como padrão compartivo (padrão ouro; figura 3 do anexo 
4 B). Entretanto, os tratamentos com dexametasona e FHe obtiveram resultados 
inferiores ao resultado obtido com o tratamento com o extrato bruto da PO6. Este 
resultado reforça o potencial anti-inflamatório do extrato bruto da PO6 como um 
produto natural de grande valor para medicina e odontologia. O sinergismo entre 
moléculas hidrossolúveis e moléculas lipossolúveis presentes no extrato bruto pode 
explicar a maior potência do extrato bruto quando comparado com a FHe. De forma 
geral, é possível que moléculas hidrossolúveis sinérgicas tenham sido removidas pela 
técnica de fracionamento com hexano. Entretanto, os dados apresentados na figura 
3B do anexo 5 mostram a FHe é uma fonte promissora de moléculas com atividade 
anti-inflamatória comparável a dexametasona.  
Uma alternativa a bioprospecção bioguiada foi a identificação de 
compostos diretamente na própolis bruta. A identificação dos compostos giberilinas 
A7, A9 e A20; ácido cafeoiltartárico, ácido 3,4-dicafeoiltartarico e quercetina; e o relato 
de diversas atividades biológicas destes compostos na literatura; concomitantes a 
presença de atividades anti-inflamatórias e antifúngicas do extrato bruto são 
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indicativos de que estas moléculas participem isoladamente ou em sinergismo da 
atividade biológica do extrato bruto da PO6 (artigo 1). 
Além disso, os achados mostrados no artigo 2 mostram que a GA4 possui 
atividade anti-inflamatória e que a GA7 possui atividade antifúngica. As giberilinas são 
um grupo muito heterogênio de terpenoides, possuindo mais de 130 moléculas 
descritas na literatura com diversas funções hormonais (MacMillan, 2001). Apesar de 
estarem descritas, muitas destas moléculas não estão disponíveis para aquisição na 
forma de padrões moleculares, e por esta razão, até o momento só realizamos 
avaliações de atividades biológicas das GA4 e GA7. 
Apesar de apresentar propriedades biológicas diferentes, as GA4 
(C19H24O5) e GA7 (C19H22O5) são quimicamente parecidas. Estas GA possuem 
fórmulas moleculares que se diferenciam apenas por 2 átomos de hidrogênio na GA4 
(2 átomos a mais) quando comparada a GA7 e uma similaridade estrutural química 
alta, possuindo como diferença a presença de uma dupla ligação no primeiro anel da 
GA7 quando comparada com a estrutura da GA4 (Figura 1). 
  
Figura 1. Estrutura química da giberilina A4 (Figura 1A)7 e giberilina A7 (Figura 1B) 8. 
 
  
 
7 https://pubchem.ncbi.nlm.nih.gov/compound/Gibberellin-A4#section=2D-Structure 
8 https://pubchem.ncbi.nlm.nih.gov/compound/Gibberellin-A7#section=2D-Structure 
A B 
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4 Conclusão 
Concluímos que o extrato bruto da PO6 possui uma potente atividade anti-
inflamatória por meio da redução da ativação do NF-κB; liberação de TNF-α e 
migração de neutrófilos. Além disso o extrato bruto da PO6 possui potente atividade 
antifúngica por atividade inibidora do crescimento e fungistática, antibiofilme e 
reduzindo a adesão em queratinócitos humanos. As atividades antifúngicas foram 
demonstradas em espécies Candida albicans, Candida glabrata, Candida tropicalis, 
Candida kruse e Candida parapsisolis. 
As moléculas giberilinas A7, A9 e A20; ácido cafeoiltartárico, ácido 3,4-
dicafeoiltartarico e quercetina podem ser responsáveis por tais efeitos biológicos. 
Destacamos a presença de giberilinas nas amostras de PO6, sendo este um achado 
inédito e nunca reportado em propolis ao redor do mundo. Concluímos também que 
as giberilinas A4 e A7 possuem atividades anti-inflamatórias, antifúngicas, 
antioxidantes e baixo perfil tóxico. É provável que outras moléculas hajam em 
sinergismo com as giberilinas para obtenção dos efeitos potentes observados no 
extrato bruto. 
Assim, nossos resultados mostram que a PO6 é uma fonte de moléculas 
bioativas de grande potencial, além de ser um produto natural que tem grande 
aplicabilidade para prevenção de doenças inflamatórias, fúngicas e oxidativas e que 
a classe dos terpenoides giberilinas pode ser responsável por estes efeitos.  
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Anexo 5 – Resultados obtidos com a bioprospecção bioguiada da 
PO6 não inclusos nos artigos 1 e 2 
 
Figura 1 (anexo 5). Cromatograma obtido na análise LC-ESI-QTOF-MS com a injeção de amostra do 
extrato bruto da PO6. Os números 26, 37, 56, 97, 102 e 113; localizados no platô dos picos; 
representam as moléculas ácido cafeoiltartárico, ácido 3,4 dicafeoilquínico, quercetina, GA7, GA20 e 
GA9, respectivamente. 
 
Figura 2 (anexo 5). Cromatograma obtido na análise HPLC-DAD com a injeção de amostra da fração 
hexânica da PO6. Picos ainda não identificados. 
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Figura 3 (anexo 5).  Viabilidade celular (A) e ativação do NF-кB (B) de macrófagos RAW 264.7 tratados 
com o veículo (“C”); PO6 a 10 µg/mL (“PO6”); dexametasona a 0,5 µg/mL (“D”); ou a fração hexânica 
da PO6 nas concentrações de 0,1; 1; e 10 µg/mL (“FHe”; na figura A apenas na concentração de 10 
µg/mL). 
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Anexo 6 – Comparação de similaridade textual (Software Turnitin) 
 
 
 
